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Abstract 
 
Bone remodeling is a physiological process by which old bone is replaced by new bone. 
Osteoclasts are multinucleated giant cells of the monocytic lineage. Their function is bone 
resorption, the first step of bone remodeling. The work of this thesis is in continuity with a 
theme long developed in our laboratory, that of the actin cytoskeleton organization in bone-
resorbing osteoclasts. Our first study investigated the role of the podosome organization in 
osteoclast spreading, adhesion and migration. Our results showed that podosome patterning 
into rings exerted outward tension upon the substrate and thereby triggered cell migration. 
Through cycles of assembly, growth and alternating disassembly, rings promote a saltatory 
mode of migration universal to all osteoclasts. 
The main objective of this thesis, however, was dedicated to finding new genes that govern 
podosome patterning in resorption-related processes such as osteoclast migration and sealing 
zone formation. To find such new genes, we employed a differential transcriptomic analysis 
of osteoclasts and osteoclast-like cells that exhibit podosomes but are unable to resorb bone. 
Among a list of six genes highly and exclusively expressed in osteoclasts, we chose to 
investigate RhoE, a constitutively active GTP-binding protein known for its regulation of 
actin structures. We provided evidence, using primary RhoE-deficient osteoclasts, that RhoE 
activity is essential to bone resorption. We unveiled a new role for RhoE in the control of 
actin turnover in podosomes through a Rock-antagonistic function. Finally, we demonstrated 
that the role of RhoE in osteoclasts is essential to their migration and sealing zone formation. 
 
 
Résumé 
 
Le remodelage osseux est un  processus physiologique de renouvellement de l’os ancien par 
de l’os nouveau. Les ostéoclastes sont des cellules multinucléées géantes dont la fonction 
principale est de dégrader la matrice osseuse, première étape de ce  remodelage. Le travail 
réalisé s’inscrit dans une thématique d’expertise de notre laboratoire, celle de l’organisation 
du cytosquelette d’actine dans les ostéoclastes résorbants. Nous avons pu élucider le rôle de la 
formation des podosomes et de leur organisation collective sur l’adhérence et la migration 
ostéoclastique. Nos résultats ont démontré que l’assemblage de podosomes sous forme de 
structures circulaires dites « anneaux » exerce une force centripète sur le substrat et ainsi 
déclenche la migration de l’ostéoclaste. L’alternance entre apparition et disparition de ces 
anneaux au sein de la cellule résulte en une migration saltatoire universelle pour tous les 
ostéoclastes. 
L’objectif principal de cette thèse était de trouver de nouveaux gènes impliqués dans 
l’organisation des podosomes. Nous avons mis en place une analyse transcriptomique 
comparant les ostéoclastes avec d’autres cellules multinucléées géantes qui présentent des 
podosomes mais sont incapables de résorber l’os. Parmi la liste de six gènes établie par cette 
méthode, nous avons étudié RhoE. En exploitant la culture d’ostéoclastes primaires déplétés 
de RhoE, nous avons démontré que ce gène est essentiel pour la migration ostéoclastique et la 
résorption osseuse. Nous avons ensuite établi que RhoE agit comme antagoniste de la voie de 
Rock pour assurer le renouvellement d’actine au sein des podosomes, ce qui entretien la 
fonction ostéoclastique. 
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I. BONE REMODELING 
 
 
I.1. The skeleton: cells and matrix 
Bone is a living tissue comprised of a stiff extracellular matrix, bone cells, blood vessels and 
nerves. The extracellular matrix is itself mineralized and composed of Type I Collagen mostly 
as well as glycoproteins and proteoglycans. Besides its obvious role in mechanical support for 
movement, bone also provides protection of vital tissues and organs as well as regulation of 
the immune, endocrine and nervous systems and mineral homeostasis.  
The growth of this tissue during development, its renewal during adulthood and its repair are 
coordinated processes ensured by the three bone cells: osteoblasts (OBs), osteoclasts (OCs) 
and osteocytes (OYs).  
I.1.1. Osteoblasts 
OBs are derived from mesenchymal stem cells. Their main function is the deposition and 
arrangement of the organic matrix of bone mainly composed at 90% of of Type I collagen. 
OBs also secrete fibronectin, osteopontin, osteocalcin and sialoprotein which allow the 
mineralization of bone after crystallization of hydroxyapatite from deposited calcium and 
phosphate (Khurana, 2009). OBs are also able to regulate OC differentiation and function 
through a variety of cytokines such as RANKL, OPG, MCSF and interleukins IL-6 and IL-11 
and growth factors such as TGF-β and BMPs. In addition, OBs can respond to two hormones 
that are central to mineral homeostasis and bone metabolism namely parathyroid hormone 
(PTH) and 1,25-dihydroxyvitamin D. With the aging of bone, OBs are thought to transform 
into “bone lining cells”, quiescent cells present at sites of bone where active bone formation is 
absent (Bartl, 2009).  
I.1.2. Osteoclasts 
OCs are multinucleated giant cells deriving from hematopoietic precursors. They are 
responsible for bone degradation, also known as bone resorption. To degrade the most 
compact and stiff matrix of the organism, OCs actively secrete protons and proteases thereby 
allowing the dissolution of its mineral phase and the breakdown of its protein scaffold, 
respectively (Coxon and Taylor, 2008b). This process ensures the release of minerals 
(Calcium, Phosphate, Magnesium,…), peptides (from degraded matrix proteins) and signaling 
molecules (TGF-β,…) formerly embedded in bone into the blood stream (Mulari et al., 
2003a; Yadav et al., 2011). Both osteoclastogenesis and bone resorption are regulated by OBs 
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through RANKL and OPG expression, by OYs through RANKL and by immune cells though 
several cytokines such as MCSF, RANKL, TNF-α, interleukins, etc ... (Nakashima and 
Takayanagi, 2011a; O'Brien et al., 2013). Conversely, OC are themselves able to regulate OB 
chemotaxis through PDGF expression (Sanchez-Fernandez et al., 2008). 
I.1.3. Osteocytes 
In contrast to bone surface cells, i.e. OBs and OCs, OYs are embedded in the bone matrix. 
They comprise more than 90% of all bone cells and are derived from OBs that became 
trapped by the bone matrix that they themselves secreted and organized. OYs are 
mechanosensory cells able to translate loading stress into facilitation of macromolecule 
diffusion. OYs are not only able to communicate with each other through gap junctions but 
are also implicated in signaling to other bone cells (Khurana, 2009). For example, they can 
modulate OB-mediated bone formation through the expression of OB-specific factor 1 (OSF-
1), dentin matrix protein 1 (DMP1) and sclerostin (Tezuka et al., 1990; O'Brien et al., 2013). 
OYs can control OCs as well by being the major source of RANKL, an indispensable 
cytokine for OC differentiation and function (Xiong et al., 2011). 
 
Bone modeling during the development and bone remodeling during adulthood occur in 
discrete foci or packets approximately 2-3mm long and with a diameter of 200-300µm 
(Gruber et al., 2008). These were termed “Bone remodeling units” (BRU) when first 
described by Frost in 1964 (Figure 1,2). Whether during bone modeling or remodeling, the 
first step during the lifetime of a BRU is always bone resorption by osteoclasts, followed by a 
reversal phase where OC-like macrophages, probably differentiating from circulating 
monocytes (Kotani et al., 2013), resorb the remainder of the fragmented collagen and finally a 
bone formation phase by OBs (Figure 1,2) (Bartl, 2009). BRUs have a lifespan of 3-9 months 
and are present in an estimated number of 106 at any time in the adult human organism (Bartl, 
2009). These BRUs are responsible for the entire renewal of the human bone matrix every 10 
years. Human BRUs outlast the lifespans of OCs (3 weeks) and OBs (3 months). Both these 
cell types are therefore constantly differentiating from new precursors that are thought to be 
delivered by blood vessels and chemically attracted or docked using matrix components 
(Gruber et al., 2008) 
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Figure 1. Chronological order of phases in a bone remodeling cycle. The first step is 
resorption of old bone by OCs. Secondly, OC-like macrophages thought to be differentiated 
from circulating monocytes (Kotani et al., 2013) remove matrix debris during the reversal 
phase. Third, osteoblasts secrete proteins that form the osteoid layer (unmineralized bone), 
which is later mineralized by the same cells to become the new bone. Osteoblasts either 
remain on the surface of bone and become lining cells or are embeded within the bone matrix 
that they secreted to become osteocytes. Osteocytes contact both osteoclasts and osteoblasts 
and can regulate their activities.  (http://imueos.wordpress.com/2010/09/29/bone-physiology/) 
 
Figure 2. Histological sections of human bone remodeling units (BRUs). (A) Hematoxylin 
and eosin stained section. BV: blood vessel; CT: connective tissue; Obl: osteoblasts; Ocl: 
osteoclasts; Ocy: osteocytes; Green arrowheads: nuclei of osteoclasts (From 
http://courses.md.huji.ac.il/histology/cartilage&bone/I-9L.html). (B) Toluidine blue-stained 
section. Osteoclasts (long arrows) advancing from left to right, have formed a resorption 
lacuna. Osteoblasts (short arrows) are laying down unmineralized osteoid matrix in the 
resorption lacuna (Boyce et al., 2012).  
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I.2. Bone pathologies: the prevalence of osteoporosis 
An imbalance in the dynamic equilibrium between bone formation and resorption can result 
in rare cases in an increase of bone mass and density called osteopetrosis, or, more often, in a 
decrease in those parameters called osteoporosis.  
Osteopetrosis is due to hereditary genetic disorders that rarely occur in humans (Balemans et 
al., 2005). However, it is a common bone phenotype in transgenic animals that are engineered 
for use in bone biology research. Examples of such animals will be mentioned in the course of 
this manuscript. 
Osteoporosis is one of the 10 most common diseases that affect humans with a prevalence of 
one in every three women and one in every eight men worldwide (Bartl and Frisch, 2004). 
Osteoporosis is the cause of bone fractures in 70% of US individuals (Khurana, 2009). 
Besides the obvious burden of these fractures on the quality of life, they pose an increased 
risk of mortality (Bartl and Frisch, 2004).  
The cause of osteoporosis in women, and in most cases in men, is the decrease in steroid 
hormones with age, which always leads first to an increase in osteoclastic resorption. Steroid 
hormones are also important for OB formation because they promote the differentiation of 
HSCs into OB while blocking differentiation into adipocytes (Gruber et al., 2008). Most of 
the clinical treatments so far used to reduce pathological decrease in bone mass have aimed at 
blocking OC-mediated bone resorption, although emerging treatments rather stimulate OB-
mediated bone formation (Marie and Kassem, 2011). 
 
I.3. Osteoimmunology  
Evidence of the regulation of bone cells by the immune system started emerging in the 1970s 
when several studies described OC-stimulating soluble factors secreted by leucocytes and 
myeloma cells. (Horton et al., 1972; Mundy et al., 1974). The first of soluble factor to be 
identified was IL-1 (Dewhirst et al., 1985) secreted by peripheral blood mononuclear cells. 
Since then, bone and immune cells have been found to share several pathways regulating 
common transcription factors, cytokines, signaling factors, receptors,… In addition to these 
molecular findings, the immediate vicinity of bone cells with hematopoietic precursors and 
immune cells within the bone marrow has raised questions about the physiological cross-
regulation between the bone and immune systems, especially on the effect of the pathology of 
one system on the other. The study of functional links between these two systems has given 
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rise to a new scientific field dubbed “Osteoimmunology” by Arron and Choi (Arron and Choi, 
2000).  
Advancements in this field have so far established a major axis of osteoimmune crosstalk:  
T-lymphocyte and macrophage regulation of OC (Takayanagi, 2009; Okamoto and 
Takayanagi, 2011b). It has been shown that different sub-populations of T cells, namely 
helper T cells, can promote OC differentiation and activity directly through RANKL, TNF 
expression and indirectly by IL-17-mediated stimulation of synovial fibroblasts and 
macrophages (Okamoto and Takayanagi, 2011a). T cells can also directly inhibit these OC 
processes through IL-4 and IFN-γ secretion. More recently, a second axis has emerged 
depicting OB regulation of hematopoietic stem cell (HSC) (Yoon et al., 2012). 
I.4. Autoimmunity in bone diseases: the case of Rheumatoid Arthritis  
A large area of osteoimmunology deals with the implication of autoimmune diseases in 
pathological bone remodeling. A major example of such an implication is the case of 
Rheumatoid arthritis (RA). RA is a systemic autoimmune disease characterized by acute 
inflammation of the joints with severe articular bone and cartilage erosion, often 
accompanied, in its late stages, by systemic inflammation-induced osteoporosis (Schett and 
Gravallese, 2012).  
RA affects about 1% of the worldwide population but its origin is still unknown McInnes, 
2011 #8386}. Current knowledge has allowed the drafting of a model of development of RA, 
although the exact molecular and physiological links remain elusive. At the preclinical stage, 
years before the actual onset of RA, the interaction of environmental factors (smoking, gut 
microbiome,.. ) with genetic and epigenetic regulation would result in post-translational 
modifications of certain self antigens (McInnes and Schett, 2011). The immune system would 
then loose tolerance to these “neoantigens” and lymphocytes would release autoantibodies in 
secondary lymphoid tissues or in the bone marrow. These autoantibodies include the 
“Rheumatoid factor” (RF) and anti-citrullinated protein autoantibodies (ACPA) (Aigner et al., 
2007; Kuna, 2012). RF recognizes the Fc portion of IgGs. ACPA recognizes the post-
translationally citrullinated proteins such as α-enolase, keratin, fibrinogen, fibronectin, 
collagen, and vimentin (McInnes and Schett, 2011). These antibodies are currently used as 
early clinical markers of RA, although their suspected contributions to the onset of the disease 
are unknown. In a recent collaboration with Pr. Georg Schett’s laboratory, we have 
demonstrated that ACPA, by recognizing citrullinated vimentin at the surface of OCs, 
markedly stimulates their differentiation by promoting an autocrine TNF-α effect in these 
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cells (see Annex section of this manuscript: Harre*, Georgess* et al). Increased osteoclast 
numbers therefore result in severe bone loss in joints (Figure 3). This study provided the first 
proof that autoantibody response to citrullinated vimentin can induce bone loss ((Harre et al., 
2012) commented in (Leah, 2012)).The maturation of RF and ACPA antibody response could 
be triggered by infectious agents, neuroimmune factors, biomechanical stimuli and/or 
microvasculature anomalies. This maturation coincides with onset of synovitis, the local 
inflammation of the synovial membrane at the joints, thus starting the clinical/symptomatic 
phase of arthritis (Figure 3) (McInnes and Schett, 2011; Komatsu and Takayanagi, 2012a). 
Lymphocytes, macrophages, neutrophiles and mast cells are then recruited to synovial 
compartment and induce the formation of pannus, an abnormal layer of fibroblast-like 
synoviocytes (FLSs) and neoangiogenesis (Pap et al., 2003; Okamoto and Takayanagi, 
2011b; Komatsu and Takayanagi, 2012b). All these cell types intricately coordinate bone and 
cartilage erosion by secreting inflammatory cytokines, namely TNF-α. The latter is therefore 
the most relevant cytokine in RA because it directly promotes OC-mediated bone resorption. 
In addition to this local bone and cartilage erosion, the chronic and systemic inflammation is 
correlated in a longer term with osteoporosis (Schett, 2012).   
 
 
 
Figure 3. Evolution of periarticular bone erosion in the course of rheumatoid arthritis 
(RA). During the preclinical phase of RA, autoantibodies that target citrullinated proteins, 
namely vimentin, are produced early on by plasma cells. Citrullination is posttranslational 
modification consisting of the replacement of an Arginine by a Citrulline. The anti-
citrullinated protein autoantibodies (ACPA) can stimulate the differentiation of osteoclasts 
and therefore lead to initial bone loss. These early changes may initiate in the bone marrow 
adjacent to the joint. Synovitis at the onset of clinical disease leads to production of cytokines 
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Osteoclast
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cell
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which stimulate osteoclastogenesis. The established phase of RA is characterized by the 
presence of large bone erosions filled with inflamed, synovially derived pannus tissue (Schett, 
2012).  
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II. OSTEOCLAST DIFFERENTIATION 
 
OCs are giant multinucleated cells that derive from the differentiation and fusion of 
mononucleated precursors. This part of the manuscript will summarize current standing on the 
identity of these precursors, the key signaling pathways involved in osteoclastogenesis and 
the link between adhesion and differentiation.  
 
II.1. Identification of osteoclast precursors  data from human and murine models 
The first documented micrograph of an OC was published by Pr. A.C. Geddes in 1913 (Figure 
4) (Geddes, 1913). “In the course of the search for the origin of the osteoblast, stated Dr. 
Geddes, the origin of the osteoclast was observed.” The OC, found in the second metatarsal of 
an 8-9 week-old human embryo, was then defined as “composed of the fused bodies of one or 
more cartilage cells, with numerous osteoblasts living within the protoplasmic mass as cell 
inclusions (multiple nuclei)”. 
 
The hematopoietic origin of the OC, however, was not described before several studies in the 
1970s (Steven, 1961; Kahn and Simmons, 1975; Walker, 1975; Mundy et al., 1977; Jotereau 
and Le Douarin, 1978; Kahn et al., 1978; Ash et al., 1980). 
In general, hematopoietic stem cells (HSCs) can give rise to two types of multipotent lineage 
progenitors: common lymphoid progenitors (CLPs) and common myeloid progenitors 
(CMPs) (Akashi et al., 2000; Xing et al., 2005a). CLPs can give rise to B and T lymphocytes 
and to natural killer cells, but not to OCs. There is one documented exception to this rule 
observed in Pax5-/- mice where pro-B cells can differentiate into OCs (Nutt et al., 1999). On 
the other hand, CMPs can give rise to megakaryocytes, erythrocytes, and 
granulocyte/macrophage progenitors (GMPs) which themselves can differentiate either 
into monocytes (Mo), dendritic cells (DCs), macrophages and osteoclasts under stimulation 
with M-CSF or into ganulocytes under stimulation with GF-MSF (Geissmann, 2007). 
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Figure 4. The first documented micrograph of an osteoclast in a histological section by  
Pr. Geddes. The figure is explained by its legend from the original publication in 1913 
(Geddes, 1913).  
The identification of the two main osteoclastogenic cytokines, M-CSF in 1993 (Tanaka et al., 
1993) and, more importantly, RANKL in 1998 (Fuller et al., 1998; Matsuzaki et al., 1998; 
Yasuda et al., 1998), accompanied by technological advancements, mainly Fluorescence-
Activated Cell Sorting (FACS), have allowed to specifically isolate human and murine 
monoclonal GMP-derived populations and test their osteoclastogenic potential ex vivo. It is 
noteworthy to mention that mice deficient of c-Fms (the M-CSF receptor), RANKL or its 
receptor, RANK, do not have OCs (Dougall et al., 1999; Pettit et al., 2001). Strikingly, all the 
data so far obtained have described wide osteoclastogenic plasticity within the myeloid 
lineage where very early myeloid precursors as well as committed monocytes, macrophages 
and dendritic cells can differentiate into OCs. 
When isolated from murine bone marrow, blood or spleen, GMPs that are expanded ex vivo 
under stimulation by M-CSF and GM-CSF are called Colony Forming Units-
Macrophage/Ganulocyte (CFU-GMs); these can give rise to CD11b+ OC precursors 
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(Roodman, 1999). Similarly, bone marrow-derived Flt3+ cells that are expanded ex vivo in the 
presence of Flt3-ligand give rise to CD11b+ CD11c- OC precursor colonies (Servet-Delprat et 
al., 2002). Cells from both CD11b+ expanded colonies can be directly differentiated not only 
into OCs, but also into macrophages and dendritic cells.  
GMPs can also differentiate into osteoclast/macrophage/DC precursors (OcMDCs) 
characterized by CD11b+ Gr-1–/lo c-Fms–/+ expression (Arai et al., 1999; Xing et al., 2005b). 
M-CSF, through its receptor c-Fms, induces proliferation and differentiation of these  
C-Fms–/+ precursors. These OcDMCs can be subsequently differentiated into OCs in the 
presence of RANKL. Further dissection of OC precursor clonality in mice has allowed a 
surface marker-based distinction between bone marrow-residing OcDMCs which had the 
following phenotype B220- CD3- CD11b/low C-Fms+ CD117hi/intermediate/low and peripheral 
OcDMCs, residing in the blood or in the spleen, which conversely had high CD11b surface 
expression (Jacome-Galarza et al., 2013). Again, similarly to the two colony-derived 
precursors described above, the CD117hi subpopulation of OcDMCs can also differentiate 
into DCs and macrophages. 
These studies have cumulatively demonstrated that OCs cannot differentiate directly neither 
from the original hematopoietic stem cells (HSCs), nor from myeloid-committed GMPs, but 
that they derive from more committed cells: OcMDCs. Within OcMDCs pool, however, 
several different sub-populations exist depending on their initial hematopoietic organs 
(CD11b-positive or  -negative) or on c-fms expression (positive or negative).  
The osteoclastogenic potential of terminally differentiated myeloid cells, i.e. macrophages, 
monocytes and DC has also been studied, adding more complexity to the scheme. In fact, 
human and murine Mo (CD14+ CD16low CD3- CD19- CD56-), human osteoarthritic 
macrophages and the murine monocytic/macrophage cell-line RAW 264.7 can all directly 
give rise into OCs in the presence of M-CSF and RANKL (Sabokbar et al., 2000; Gallois et 
al., 2010). More strikingly, Mo-derived immature DCs (CD1a+ CD14- HLA a,b,cint, HLA 
DRint, and CD80low, CD83low, and CD86low) can also directly differentiate into OCs, even 
more efficiently so than Mo. Indeed, a transcriptome-wide study showed that OCs are 
transcriptionally closer to DC than to Mo (Rivollier et al., 2004; Speziani et al., 2007; Gallois 
et al., 2010). 
In conclusion, the origin of the OCs does not seem to be unique. However diverse and 
complex, information about the origin of OC precursors remains physiologically relevant 
because it may assist in answering three other questions: (1) Where does osteoclastogenesis 
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take place in the body? (2) Does it occur before or after recruitment on the site of resorption?  
(3) Are OCs a unique population or do OC subtypes exist? 
 
II.2. The site of osteoclast differentiation 
It is unclear, in vivo, whether or when OCs are derived from circulating precursors or bone-
tissue-resident precursors. One hypothesis claims that precursors in bone marrow or near bone 
can differentiate into OCs on adjacent sites where resorption is needed. Resorption activity, 
unlike hematopoiesis which is widespread in the marrow, occurs focally i.e. heterogeneously 
across the bone matrix. This hypothesis would then suggest the presence of a mechanism that 
spatially directs the initiation of differentiation to where resorption activity is needed. 
Although mature OCs are themselves capable of migration through cell layers (Saltel et al., 
2006), data supporting the stated hypothesis per se has not yet been published. A second 
hypothesis claims that OC precursors leave hematopoietic tissues, invade the systemic 
circulation and are homed to site of bone requiring resorption (Muto et al., 2011). This 
hypothesis implies that OC precursors have a significant migration capacity. Indeed, OC 
precursors are capable of migrating and the genetic depletion of the Hck gene, that promotes 
their migration, results in impaired homing to bone sites in vivo and, consequently, to reduced 
differentiation (Verollet et al., 2013). In addition to the studies mentioned in the previous 
paragraph depicting the high ex vivo osteoclastogenic potential of circulating myeloid cells, 
more recent work using in vivo two-photon microscopy in mice has showed that OC 
precursors originating from the spleen can transmigrate into the systemic circulation, enter the 
bone spaces and differentiate into OCs (Kotani et al., 2013). Lipid mediators and some 
chemokines such as sphingosine-1-phosphate (S1P), SDF-1/CXCL12 and RANKL have been 
shown to regulate this homing process (Ishii et al., 2009). In addition, in RA murine models, 
CD11b+ precursors have been shown to be mobilized by inflammatory cytokines, mainly 
TNF-α and RANKL, towards sites of increased OC bone erosion in the joint where the 
presence of mature OC was significantly increased (Ritchlin et al., 2003; Li et al., 2004). 
Interestingly, in RA patients, DC numbers are severely increased in the synovium. The 
differentiation of these DCs into OCs ex vivo has been highly induced by RA synovial fluid 
extracted from patients (Rivollier et al., 2004).  
Given the accumulation of evidence albeit not absolutely demonstrative, the second 
hypothesis on the whereabouts of osteoclastogenesis seems more plausible. Finally, one 
common fact, regardless of the originating location of OC precursors, is that the terminal 
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phase of differentiation of already committed OC precursors cannot occur away from the 
bone tissue because of the main sources of RANKL, essentially OYs and OBs, are bone-
residing. 
 
II.3. Relevant cytokines involved in osteoclast differentiation 
Several cytokines and their respective receptors are essential for OC precursor differentiation 
and fusion. Their sources, downstream signaling pathways and spatio-temporal roles are 
distinct.  
II.3.1. M-CSF  
M-CSF is a key cytokine for the determination of precursors commitment into the 
macrophage/OC lineage (MacDonald et al., 1986)(Figures 5,7). Its osteoclastogenic function 
was identified in the early 1990s. In fact, investigators searching for the genetic factor behind 
the absence of OC and consequent osteopetrosis in op/op mice found that it was the alteration 
of the M-CSF gene expression (Wiktor-Jedrzejczak et al., 1990; Kodama et al., 1991). M-
CSF is produced constitutively in the bone microenvironment by a range of cells, including 
stromal cells/OB and T-lymphocytes in response to high PTH levels and inflammatory 
molecules such as TNF-α and IL-1 (Weir et al., 1996; Yavropoulou and Yovos, 2008). By 
binding to its sole receptor, c-fms (also known as CSF1-R, at the cell membrane, M-CSF 
promotes the proliferation, survival, and early commitment of OcMDCs (Figures 5,7). When 
recognized by its ligand, the receptor dimerizes and its tyrosine kinase is activated leading to 
auto-phosphorylation of specific tyrosine residues. This launches a downstream signaling 
cascade that includes PI3K, ERK1/2, PLC-γ and the proto-oncogene c-CBL (Ross, 2006). M-
CSF can induce the expression of its own receptor, c-fms, by an autocrine loop that amplifies 
M-CSF-mediated signals, while it has also been reported to stimulate PU.1, an essential 
transcription factor in osteoclastogenesis (see below section II.4.1. PU-1). M-CSF can also 
induce the expression of RANK, the receptor of RANKL which is another indispensible 
cytokine in OC differentiation (Figure 7). The mutation of the M-CSF gene in op/op mice or 
in tl/tl rats causes a marked decrease of tissue macrophages and a lack of OCs resulting in an 
osteopetrotic bone phenotype (Wiktor-Jedrzejczak et al., 1990; Yoshida et al., 1990; Dobbins 
et al., 2002a; Dobbins et al., 2002b)). Accordingly, the genetic knockout of c-fms also leads 
to osteopetrosis in mice (Dai et al., 2002).  
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II.3.2. RANKL/RANK/OPG triad: 
A “giant leap” for OC research was the characterization of the indispensable role of RANKL 
in osteoclastogenesis (Figures 5-7). RANKL, a member of the TNF family, has been first 
identified on the surface of activated T-lymphocytes where it participates in the survival and 
activation of DCs (Anderson et al., 1997; Wong et al., 1997). RANKL had several other 
names prior to the specific identification of its importance for OCs. Some of these names 
were related to its general functions like “TNF-Related Activation-Induced Cytokine” 
(TRANCE) for example. Other names, however, were more specific of its OC-targeting 
function as its identification became more imminent, such as Osteoclast Differentiation Factor 
(ODF), and more importantly, Osteoprotegerin(OPG)-Ligand. OPG, a molecule also 
belonging to the TNF family, was identified as a secreted inhibitor of OC differentiation in 
vivo and in vitro (Simonet et al., 1997) (Figures 6,7). It was not before several studies in 1998 
that the antagonist of OPG was found to be the immune cytokine RANKL (Fuller et al., 1998; 
Lacey et al., 1998; Yasuda et al., 1998). RANKL and its receptor RANK were therefore 
established as important for the development of the immune system (e.g. lymph nodes) and 
the bone tissue (Dougall et al., 1999). In bone, secreted OPG acts as a decoy receptor for 
RANKL thus blocking its binding to RANK (Simonet et al., 1997; Yasuda et al., 1998) 
(Figures 6,7). RANKL is synthesized by OBs, stromal cells, hypertrophic chondrocytes, B- 
and T-lymphocytes, osteocytes and even OCs themselves. Upon its synthesis, RANKL is 
relocated at the membrane of the cell and can be cleaved by proteases such as TNF-α 
convertase (TACE), Matrix Metalloprotease-14 (MMP-14) and A Disintegrin And 
Metalloprotease family member 10 (ADAM-10) (Hikita et al., 2006). Its most functionally 
dominant role is when it remains at the surface of source cells and acts through cell-cell 
contact. Although OBs had been considered for many years as the primary physiological 
source of RANKL to OCs, two distinct studies using mouse genetic models recently described 
OYs as the major source of RANKL needed for OC differentiation (Nakashima and 
Takayanagi, 2011b; Xiong et al., 2011). It is currently claimed that OYs are the major source 
of OPG as well (O'Brien et al., 2013). The ratio of RANKL/OPG is therefore crucial for bone 
resorption. An interesting challenge in the future of bone research would be to understand 
why and how the same cells, OYs, induce and inhibit OC differentiation and activity. 
Because RANK lacks intrinsic enzymatic activity in its intracellular domain, after it is bound 
by RANKL, it recruits adaptor molecules such as TRAF family proteins, namely TRAF6 
which transduces NF-κB and mitogen-activated kinases (MAPKs) pathways that include Jun 
p38 and N-terminal kinase (JNK), respectively (Matsumoto et al., 2004; Vernejoul and Marie, 
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2008) (Figures 5,6). RANK thereby activates several key transcription factors including AP-1 
through its component c-fos and NFATc1 through NF-κB and c-fos signaling (Figure 6). 
Genetic depletions is these key signaling molecules in osteoclastogenesis such as RANKL-/-, 
RANK-/-, TRAF6-/- and c-fos-/- lead to osteopetrosis in mice due to the absence of 
differentiated OCs (Grigoriadis et al., 1994; Dougall et al., 1999; Kong et al., 1999; Lomaga 
et al., 1999). Conversely, OPG-/- mice are osteoporotic due to lack of OC activity (Bucay et 
al., 1998; Mizuno et al., 1998). Given the central role of RANKL, a monoclonal antibody 
targeting it, Denosumab, is now clinically administered for the treatment of several bone 
pathologies such as rheumatoid arthritis, giant cell tumor of bone, … (Dempster et al., 2012). 
 
 
 
Figure 5. Schematic representation of major ligand-receptor systems in OC 
differentiation and function regulated by TNF-α, ODF/RANKL, and IL-1α. TNF-α and 
RANKL (also known as Osteoclast Differentiation Factor, ODF) independently stimulate 
osteoclast differentiation. OC differentiation induced by TNF-α occurs via TNFR1 and 
TNFR2 expressed by osteoclast precursors (here abbreviated as M-BMMϕ for Monocytes-
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Bone Marrow Macrophaghes). ODF/RANKL induces osteoclast differentiation through 
RANK-mediated signals. M-CSF is a common factor required for both TNF-α– and 
ODF/RANKL-induced osteoclast differentiation. Activation of osteoclasts is induced by 
ODF/RANKL and IL-1α through RANK and type 1 IL-1 receptor, respectively. Common 
signaling cascades such as NF-κB and JNK activation may be involved in the differentiation 
and activation of osteoclasts induced by TNF-α, ODF/RANKL, and IL-1α (Kobayashi et al., 
2000).  
II.3.3. TNF-α/IL-1  
TNF-α is the predominant inflammatory cytokine in immuno-mediated pathological bone 
resorption. It can be secreted along with RANKL by activated lymphocytes, synovial 
fibroblasts and macrophages in the vicinity of OCs. This cytokine can induce 
osteoclastogenesis in two manners i.e. directly, by acting on OCs, or, indirectly by stimulating 
proximal cells to express RANKL, IL-1 and IL-1R (Wei et al., 2005). Once secreted, both 
TNF-α and IL-1 are potent inducers of OC differentiation through their respective receptors 
on the surface of OC precursors. TNF-α has two cell surface receptors, TNFR-I and TNFR-II, 
which are expressed in various cell types including HSCs (Kobayashi et al., 2000) (Figure 5). 
When TNFR-I is bound, it activates the TRADD/TRAF pathway leading to a regulation of 
caspase-mediated apoptosis. When TNFR II is bound, it interacts with TRAFs 2, 5 and 6 
resulting in the activations of NF-κB and JNK pathways (Figure 5). Due to its ability to 
overlap RANKL/RANK signaling, TNF-α potently induces osteoclastogenesis (Kobayashi et 
al., 2000).  
Like TNF-α, IL-1 is also secreted by macrophages and stromal cells and present at bone 
erosion sites linked with inflammation, e.g. rheumatoid arthritis. Since IL-1 and its receptor, 
IL-1R, expression by stromal cells and macrophages in the vicinity of OCs is promoted by 
TNF-α, IL-1 is considered downstream of TNF-α in this signaling interplay. When IL-1 binds 
to its receptor IL-1R, its leads to the activation of the TRAF6-dependent NF-κB and JNK 
pathways via MyD88 and IRAK recruitment (Kwan Tat et al., 2004) (Figure 5). Due to the 
overlapping of their signaling with that of RANKL, TNF-α and/or IL-1R have 
osteoclastogenic effects that are synergetic with RANKL (Thomson et al., 1987; Konig et al., 
1988) (Figure 5) but a minimal level of RANKL is still required for osteoclastogenesis in vivo 
and in vitro (Kwan Tat et al., 2004).   
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It is now clear that the signals induced by the pro- and anti-osteoclastogenic cytokines 
modulate a variety of complex intracellular processes that will determine the fate of the 
precursors. Once vital process that is controlled by these cytokines is the expression and 
activity of certain transcription factors during OC differentiation. 
 
II.4. Transcription factors involved in OC differentiation and function 
The differentiation of HSCs all the way to OCs is comprised of sequential stages that are 
tightly regulated by several transcription factors. For example, PU.1 and PAX5 are “early” 
factors responsible for steering HSCs either into CMPs or CLPs, respectively. Other factors 
such as MITF, NF-κB and NFATc1 control later stages of osteoclastogenesis and 
lymphopoiesis.  
II.4.1. PU.1 
PU.1 is a member of the ETS transcription factor family characterized by its DNA-binding 
domain ETS. PU.1-/- mice, in addition to suffering from a lethal immune deficiency linked to 
the absence of B-lymphocytes and macrophages, are also osteopetrotic and devoid of OCs 
(Tondravi et al., 1997). PUI.1 regulates therefore both the lymphoid and myeloid lineages, 
mainly through its expression levels (Figure 7). In other words, low levels of this transcription 
factor in HSCs lead to their differentiation into CLPs and high levels leads to macrophages, 
that can differentiate into OCs in theory, all the while inhibiting B-cell transition (DeKoter 
and Singh, 2000). 
II.4.2. PAX5 
PAX5 is a member of a large family of transcription factors that are highly conserved during 
evolution and responsible for development and morphogenesis. PAX5-/- mice do not have 
mature B-lymphocytes and therefore die a few days post-birth. Additionally, these mice 
exhibit a sever increase in OCs numbers and are osteopenic (i.e. with low bone mass but still 
higher than in osteoporosis) (Horowitz et al., 2004). Interestingly, the PAX5 gene encodes the 
protein B-cell-lineage-specific activator protein (BSAP) that is expressed only in B-
lymphopoietic lineage, downstream of PU.1; it is undetected in OBs and OCs. The ablation of 
PAX5 in mice results in the expansion of spleen-derived c-fms+ Mac-1+ FcRγ+ B220- 
macrophage precursors that are highly osteoclastogenic. This population would be otherwise 
repressed by PAX5 expression (Horowitz et al., 2004; Horowitz and Lorenzo, 2007a, b). 
PAX5 has also been shown to repress other lineage-specific genes such as Flt3 (required for 
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multipotent B-cell progenitors), c-fms (OcMDCs) and Notch 1 (T-cells) (Nutt et al., 1999; 
Souabni et al., 2002; Holmes et al., 2006). Given these properties, PAX5 is now considered to 
be an “early” repressor of osteoclastogenesis.  
II.4.3. MITF 
Microphtalmia-associated transcription factor (MITF) is the most characterized member of 
the MIT family of transcription factors. An important functional aspect of MITF activity 
during osteoclastogenesis lies in its cooperation with other transcription factors to promote the 
expression of proteinase, essential molecules for bone degradation (Luchin et al., 2000). By 
interacting with PU.1, MITF can promote the expression of the TRAP gene, a protease that is 
critical for bone resorption (Luchin et al., 2000) (Figure 7. MITF also associates with TFE3 to 
drive Cathepsin K expression (Motyckova et al., 2001). The spontaneous ophthalmic 
mutation “mi” in the DNA-binding domain of MITF1 results in the blockade of expression of 
its target genes (Mansky et al., 2002a; Mansky et al., 2002b). Consequently, mi/mi mice are 
osteopetrotic and do not form OCs. Interestingly, RANKL is overexpressed in the bone 
marrow of these mice suggesting that MITF participates in the negative autoregulation of 
RANKL (Tagaya et al., 2000). B-lymphopoiesis in these mice is affected in vivo but not in 
vitro and it has been suggested that osteopetrosis could be responsible for this in vivo 
phenotype by reducing the available space within the bone medulla (Franzoso et al., 1997) 
(Tagaya et al., 2000).  
II.4.4. NF-κB  
Transcription factors of the NF-κB/Rel family are ubiquitously expressed and include 5 
members in mammals: p65 (RelA), c-Rel, Rel-B, NF-κB1 (p50/p105) and NF-κB2 
(p52/p100). To be functional, these members form homo- or heterodimers translocate from 
the cytoplasm to the nucleus where they regulate transcription on chromatin sites. Many 
murine knockout models have shown the importance of NF-κB family in OC differentiation 
(Franzoso et al., 1997). For example, the expression of p50 and p52 is required in OC but not 
macrophages, indicating that NF-κB acts on precursors that are already specifically 
committed to osteoclastogenesis, i.e. downstream of PU.1 (Yamashita et al., 2007b) (Figures 
5-7). 
II.4.5. c-Fos and AP-1 complex 
Along with Fra1, Fra2 and FosB, c-Fos is part of the Fos family genes. Its viral homologue,  
v-Fos, induces osteosarcoma in mice (Matsuo and Ray, 2004). Fos family members each 
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carry the highly conserved “basic leucine zipper” structure responsible for DNA-binding and 
for heterodimerization, typically with Jun proteins. This dimerization results in the 
transcription complex called Activator Protein  1 (AP-1) (Figure 6). The only component of 
AP-1 so far demonstrated as indispensable for OC formation is c-Fos. Mice lacking c-Fos 
have all suffered from impaired osteoclastogenesis coupled with osteopetrosis (Johnson et al., 
1992; Wang et al., 1992; Grigoriadis et al., 1994), thus revealing the importance of this gene 
in the myeloid lineage. Although c-Fos depletion can be rescued in vivo and in vitro by 
exogenous expression of its family member Fra1, the endogenous expression of the latter is c-
Fos-dependent. Furthermore, c-fos induced the expression of another OC-differentiating 
transcription factors, NFATc1 (see below, section II.4.6. NFATc1). RANKL and Ca2+-
signaling are both known to activate c-fos (Figure 6) while IFN-γ is known for its inhibition 
(Takayanagi et al., 2000). In addition, but both c-fos and NFAT can interact at the protein 
level and cooperatively bind to DNA to launch transcription at promoter sites (Matsuo and 
Ray, 2004).  
II.4.6. NFATc1 
Transcription factors of the Nuclear factor of activated T cells (NFAT) family have been 
shown to regulate a diverse set of functions in several tissues and the immune system. This 
family is comprised of five members: NFAT1 (NFATc2), NFAT2 (NFATc1), NFAT3 
(NFATc4), NFAT4 (NFATc3) and NFAT5. NFAT1, 2, 3 and 4 are regulated by 
calcineurine/calcium signaling (Takayanagi, 2007). They are activated when engaged by 
receptor adaptors linked with calcium signaling such as FcRγ and KARAP/DAP12 of the 
Immunoreceptor Tyrosine-based Activation Motif (ITAM) family. The engagement of these 
receptors leads to the activation of phospholipase C-γ (PLC-γ) which in turn liberates calcium 
from the endoplasmic reticulum and thus allows its binding to calmodulin. Ca2+-bound 
calmodulin thus activates calcineurin, a serine-threonine phosphatase, which relocates NFAT 
to the nucleus (Figure 7) (Vernejoul and Marie, 2008). The importance of NFATc1 to 
osteoclastogenesis was first highlighted by Takayanagi and colleagues in the course of a 
highthroughput study of RANKL-induced genes in OCs (Takayanagi et al., 2002a). They 
found that this gene was the most highly induced 24 to 72 hours post-induction with RANKL. 
Additionally, NFATc1-/- myeloid progenitors could not differentiate into OCs. RANKL acts 
on NFATc1 in two distinct mechanisms during this process. First, RANKL induces its 
expression via c-fos and TRAF6 (Figures 6,7) (Takayanagi et al., 2002b). Indeed, in c-fos-/- 
and TRAF6-/- OCs, NFATc1 is barely induced. Second, RANKL produces calcium oscillation 
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thus resulting in calcineurin-dependent NFATc1 sequestering in the nucleus (Takayanagi, 
2007; Negishi-Koga and Takayanagi, 2009). The chemical inhibition of calcineurin in murine 
bone marrow OCMDCs not only blocks this nuclear translocation but also inhibits NFATc1 
mRNA transcription, indicating that NFATc1 is responsible for its auto-amplification 
(Takayanagi, 2007).  
 
Figure 6. Schematic of signaling cascades in osteoclast differentiation. Osteoclastogenesis 
is supported by osteoblasts or bone marrow stromal cells, which provide RANKL, M‐CSF, 
and poorly characterized ligands for costimulatory receptors. RANKL binding to RANK 
results in the recruitment of TRAF6, which activates NF‐κB and MAPKs. The induction of 
NFATc1, a key transcription factor for osteoclastogenesis, is dependent on the transcription 
factors AP‐1 (containing c‐Fos) and NF‐κB. Costimulatory signals for RANK: 
immunoreceptors associated with ITAM‐harboring adaptors stimulate Ca2+ signaling. 
NFATc1 is translocated to the nucleus after the dephosphorylation by calcineurin that is 
activated by calcium (Ca2+) signaling. Ca2+/calmodulin kinases IV is a main kinase that 
activates cAMP response element‐binding protein (CREB), which is also important for 
osteoclast differentiation. Induction of c‐Fos is partly mediated by CREB. In the nucleus, 
NFATc1 works together with other transcription factors, such as AP‐1, PU.1, MITF, and 
CREB, to induce various osteoclast‐specific genes (Takayanagi, 2007). 
 
 
(OSCAR, TREM,  …) 
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NFATc1 is the master regulator of osteoclastogenesis. Its central role is supported by the fact 
that its overexpression in c-Fos-/- mice rescues the defect in osteoclastogenesis (Matsuo K 
2004 JBC). In OCs, the calcium flux needed for NFATc1 activation is mediated by the 
phosphorylation of the ITAM adaptors DAP12 and FcRγ (Takayanagi et al., 2002a; Koga et 
al., 2004; Despars et al., 2013). This pathway is synergetic with RANKL/RANK signaling 
and the two converge in a signaling complex that contains phosphorylated adaptors (BLNK 
and SLP76) and Tec family kinases, downstream of FcRγ and RANK, respectively. This 
complex is responsible for the induction and activation of NFATc1 (Ikeda et al., 2004; Koga 
et al., 2004; Matsuo et al., 2004). However, NFATc1 expression has to be tightly tuned to 
avoid excessive osteoclastogenesis. Indeed, during the early stages of differentiation, strong 
repression is exerted on the promoter of NFATc1 by negative regulators of osteoclastogenesis 
such as IRF8, MafB and Bcl6. But as differentiation develops, these negative regulators are 
blocked by Blimp-1 thus allowing NFATc1 expression (Nishikawa et al., 2010). Additionally, 
Leukemia Related Factor (LRF) negatively regulates NFATc1 in the early phase of 
differentiation but, as differentiation proceeds, its expression level increases and it becomes a 
positive co-factor of NFATc1 (Tsuji-Takechi et al., 2012). 
Once activated, NFATc1 directly regulates a number of OC-specific genes. Using promoter 
analyses and chromatin immunoprecipitation techniques, it has been shown that TRAP, 
calcitonin receptor (Takayanagi et al., 2002a), cathepsin K (Matsumoto et al., 2004), β3 
integrin (Crotti et al., 2006) and OSCAR (Kim et al., 2005a) expression are NFATc1-
dependent in OCs (Figure 6). The AP-1 complex (previously described in the c-Fos 
paragraph) has been shown in some cases to be the DNA-binding partner of NFATc1. Indeed, 
AP-1 and NFATc1 co-binding is required for transcription of TRAP and calcitonin receptor 
genes as well as the autoamplification of NFATc1 (Yamashita et al., 2007a). NFATc1 can 
also cooperate with PU.1 and MITF in the effect on the cathepsin K and OSCAR promoters 
(Matsumoto et al., 2004). Both PU.1 and MITF, which had been previously suspected as only 
relevant to the survival of early OC precursors, are therefore also important in the induction of 
late-stage differentiation of OCs. Together with NFATc1, these transcription factors make an 
OC-specific gene induction complex. This cooperation between NFATc1 and either PU.1 or 
MITF is however not always observed (Figure 7), such as in the case of the calcitonin 
receptor promoter (Kim et al., 2005a), suggesting that the component variability of this 
complex can contribute to gene-specific spatiotemporal regulation of transcription 
(Takayanagi, 2007). Finally, it is worth noting that despite its unambiguous importance 
during osteoclastogenesis, NFATc1 is not the only member of the NFAT family to intervene 
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during this process. NFATc2 has also been shown to be important in this context (Ikeda et al., 
2004). 
 
 
In conclusion of sections II.1 and II.2, it is worth noting that, although a full “molecular map” 
of the elements regulating OC differentiation is not yet available, serious advancements have 
allowed the establishment of a working model that depicts how the most essential cytokines, 
transcription factors and OC markers intervene during osteoclastogenesis (Figure 7). 
 
 
 
 
Figure 7. Regulation of OC differentiation. OCs are derived from myeloid precursors. 
Macrophage colony-stimulating factor (M-CSF) induces myeloid precursors to differentiate to 
osteoclast precursors that express RANK (Receptor activator of NF-κB) and TREM2 
(Triggering receptor expressed by myeloid cells-2) receptors. Upon RANK ligand (RANKL) 
stimulation and ITAM (Immunoreceptor tyrosine-based activation motif) activation, 
osteoclast precursors undergo further differentiation to mononuclear osteoclasts with NFATc1 
(Nuclear factor of activated T cells, cytoplasmic 1) induction and express osteoclast-related 
genes such as those encoding Tartrate-resitant acidic phosphatase (TRAP), cathepsin K 
(CtsK) and αvβ3. Mononuclear osteoclasts then fuse to multinuclear osteoclasts and function 
as polarized bone resorbing cells. This process of osteoclast differentiation is regulated by 
various transcription factors and exogenous factors at different stages. Inflammatory factors 
that promote osteoclastogenesis are shown in red. Inhibitors of osteoclastogenesis are shown 
in blue. Calc, calcitonin; Calc R, calcitonin receptor; CSF-1R, colony stimulating factor 1 
receptor; DC-STAMP, dendritic cell-specific transmembrane protein; ECM, extracellular 
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matrix; GM-CSF, granulocyte-macrophage colony-stimulating factor; M-CSF, macrophage 
colony-stimulating factor; MITF, microphthalmia-associated transcription factor; OPG, 
osteoprotegerin; TLR, Toll-like receptor (Zhao and Ivashkiv, 2011). 
 
II.5. OC precursor fusion 
 
As a result of stimulation by RANKL, RANK+ OC monocytic precursors undergo cell-cell 
fusion to form giant multinucleated bone-resorbing cells. Why functional OCs need be 
multinucleated to efficiently degrade bone is not understood. It is widely hypothesized that 
mononucleated RANK+ TRAP+ cells are not efficient in bone resorption but there is no 
evidence neither supporting nor disproving this hypothesis in mammals. In teleost fish, for 
example, the majority of resorbing OCs is mononucleated. However, several drastic 
differences in the bone and immune systems exist between of mammals and fishes, including 
the absence of haematopoietic bone marrow and of OYs (Witten and Huysseune, 2009). 
Usually, bone tissue sections in mammals as well as ex vivo differentiated OCs simply show 
that OCs cells resorb bone in their multinucleated state. As for the precursor fusion process, 
extensive videomicroscopy of OCs differentiating in culture performed in our lab over the 
past 10 years has made it quite clear that fusion is not a random process. Prior to fusion, cells 
seem to select their fusing partner and to repulse other cells after a cell-cell contacts that is 
maintained for a certain period of time (minutes to hours) before a decision is made.  
Whilst M-CSF is responsible for the proliferation, survival and early steering of myeloid 
precursors into the osteoclast pathway, RANKL is the main cytokine controlling cell-cell 
fusion and terminal osteoclastogenesis. RANKL signaling initiates a cascade of gene 
expression that includes the production of chemokines such as RANTES as well as MCP-1 
and its two receptors CCR2 and CCR4. These are chemotactic molecules able to signal to 
monocytes (Kim et al., 2005b). Chemokine-mediated fusion is thought to transduce RANK- 
quiescent precursors to fuse with RANK+ ones. In the absence of RANKL signaling, MCP-1 
has been shown to stimulate TRAP and CTR by inducing NFATc1 in rheumatoid arthritis, but 
the resulting multinucleated cells did not resorb bone efficiently (Kim et al., 2006). This 
proves the presence of a more important RANKL-mediated mechanism of fusion: activating 
NFATc1 to bind to promoter region and activated the expression of DC-STAMP and 
ATP6V0D2 (Lee et al., 2006). DC-STAMP-expression at the surface of OC precursors is 
sufficient to make them fuse with DC-STAMP- precursors. In that manner DC-STAMP 
expression is passed on from a single cell to a binucleated cell which in turn can recruit 
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another DC-STAMP- mononucleated precursor, etc… (Vignery, 2005). DC-STAMP-/- and 
ATP6V0D2-/- mice are osteopetrotic as a result of perturbed OC fusion leading to absence of 
OCs (Lee et al., 2006). The genetic depletion of these fusion genes highlights the importance 
of fusion to bone resorption activity.  
When differentiated ex vivo in culture-treated dishes, fully differentiated murine marrow- or 
spleen-derived OCs in the presence of M-CSF and RANKL can contain up to 100 nuclei per 
cell. However, a much lower number of nuclei is seen in murine OCs in vivo (histological 
section of bone tissue) or when these murine precursors are differentiated on bone (Jurdic lab, 
unpublished data). This puts forth the possibility of a matrix-dependent control as well as 
other possible physiological limitations of fusion. This discrepancy of nuclei numbers 
between in vivo and in vitro is not observed in human osteoclasts.  
 
 
II.5.  Matrix-cytokine converging pathways in osteoclastogenesis    
 
The priming of myeloid precursors, their fusion and their homing in the bone 
microenvironment is accompanied by costimulatory signals from the bone matrix. Indeed, 
matrix proteins are recognized by activated surface receptors of differentiating OCs and 
contribute to (1) the differentiation process and (2) to the launching of degradation-related 
functions once OCs are fully differentiated. The second step is also known as OC maturation.   
II.5.1. OSCAR-RANKL axis: 
RANKL induces for the expression of an OC-specific member of the Leukocyte Receptor 
Complex (LRC) protein family: OSCAR (Kim et al., 2002). This immunoglobulin-like 
receptor is expressed in OC precursors and mature OCs in humans in mice and recognizes 
collagens I, II and III (Barrow et al., 2011). Although collagen I is the predominant collagen 
in bone, collagen III is, along with collagen I, expressed by OBs and by RANKL+ endothelial 
cells of the microvasculature (Barrow et al., 2011). The matrix-independent role of OSCAR is 
to co-stimulate RANKL signaling through FcRγ, a member of the ITAM adaptor family 
(Figure 5). Another role of OSCAR has also exists. By binding to specific helical motifs in 
these collagens, OSCAR can potently induce osteoclastogenesis independently ITAM adaptor 
family members such as FcRγ and DAP12 (Kim et al., 2002). In fact, OSCAR overexpression 
was shown to recue the osteoclastogenesis defect in DAP12-/- mice and OC differentiation ex 
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vivo from humans suffering from DAP12 mutations (Barrow et al., 2011). In conclusion, 
given the ability of OSCAR to recognize collagen and its high osteoclastogenic potential in 
synergy with activate RANK, it is hypothesized that OSCAR+ RANK+ OC precursors can 
therefore be properly directed along RANKL+ vessels ending in the bone microenvironment, 
then docked on collagen I/III+ bone surface cells and naked collagen I+ bone sites to reach 
degradation-requiring destinations (Barrow et al., 2011). The complete molecular mechanism 
corresponding to matrix-dependent OSCAR signaling is not yet revealed.  
II.5.2. Integrin-RANK and Integrin- MCSF axes:  
The αV family of integrins recognizes the Arg-Gly-Asp (RGD) amino-acid motif that is 
present in several bone matrix proteins such as bone sialoproteins and osteopontin. Integrins 
are transmembrane receptors have a long extracellular domain and a shorter intracellular 
domain (Hynes, 2002). This allows them not only to bind and transmit signals from the 
extracellular matrix into the cell, therefore accomplishing what is called “outside-in” 
signaling, but also to be modulated by signals within the cell, a process called “inside-out 
signaling” (Hynes, 2002). Integrins are differentially expressed by OCs along their 
differentiation: αVβ5 is initially expressed in M-CSF-stimulated bone marrow macrophages 
but its expression is lost in favor of αVβ3 after exposure to RANKL (Lakkakorpi and 
Rajaniemi, 1991; Inoue et al., 1998; Lane et al., 2005; Teitelbaum, 2007). OCs also express 
α2β1, αVβ1 and α9β1 but αVβ3 is the most abundant and therefore the principal integrin in 
OCs (Rao et al., 2006). It is currently admitted that αVβ3 has 2 distinct functions during OC 
differentiation and maturation: (1) c-fms-dependent stimulation of osteoclastogenesis and (2) 
RANK-dependent cytoskeletal organization (Teitelbaum, 2007).  
In mice lacking the β3 subunit, the resorptive capacity is abolished due to defects in OC 
cytoskeleton and cell spreading (McHugh et al., 2000). The cytoskeleton-specific interplay 
between αVβ3 and RANK is, in fact, mediated by another relevant molecule to actin 
arrangement: c-Src. In RANKL-stimulated OCs, αVβ3 and activated RANK coprecipitate in 
vitro uniquely in the presence of c-Src. The latter binds ligand-linked RANK via its SH2 
domain and αVβ3 via SH3 domain, thus providing a possible link between these two 
receptors (Teitelbaum, 2007). More detailed descriptions of the role of integrins and Src in 
OC cytoskeletal arrangement are available in section  
Molecular studies, however, have shown that the importance of αVβ3 during OC 
differentiation is actually mediated by M-CSF and its receptor c-Fms. In β3-/- mice, OC 
numbers are increased in vivo although osteoclastogenesis is attenuated ex vivo. 
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Physiologically, mice have low circulating Ca2+ and they suffer from osteosclerosis (i.e. 
increased bone density) with age (McHugh et al., 2000). Having hypothesized that differential 
cytokine conditions between the two environments, i.e. between real bone marrow and 
experimental tissue culture, could be responsible for this paradox, Faccio and colleagues have 
demonstrated that high doses of M-CSF, but not RANKL, recues β3-/- osteoclastogenesis in ex 
vivo bone marrow cultures (Faccio et al., 2003b). The authors have proposed a molecular 
mechanism through which c-Fms occupancy and subsequent phosphorylation on Y697 are 
responsible for ERK and c-fos upregulation and, ultimately, stimulation of differentiation 
(Faccio et al., 2003b).  
II.5.3. Is adhesion required for differentiation?  
Osteoclastogenesis seems to integrate signals from specific cytokines and from the matrix via 
integrins and other receptors. These have an unequivocal role during the bone resorption 
process in mature OCs, but the extent of their contribution to OC differentiation is still 
controversial. A study by Mochizuki and colleagues has shown that the culture of OC 
precursors in the presence of M-CSF and RANKL on a 2D non-adherent substrate markedly 
reduces RANK expression and OC differentiation efficiency (Mochizuki et al., 2012). These 
precursors adopt macrophage instead of OC characteristics, thus suggesting that the adhesion 
of precursors to the substratum in required for osteoclastogenesis. Even more, the chemical 
inhibition of integrins with an RGD-containing disintegrin in OC precursors also reduces 
RANK expression and OC differentiation (Mochizuki et al., 2012). The importance of 
adhesion, but not integrin-mediated signaling per se, in osteoclastogenesis has been 
confirmed by a more recent study (Touaitahuata et al., 2013). The role of CD44, a non-
integrin OC receptor, in OC differentiation (Chabadel et al., 2007) has not yet been addressed. 
Starting from the earliest stages of their differentiation, OCs precursors exhibit at their ventral 
surface integrin-based, actin-rich adhesive puncta called “podosomes” that are thought to 
maintain adhesion, cell spreading and migration in a wide range of cells (Linder et al., 2011a) 
(Jurdic et al., 2006). Whether podosomes are required for OC precursor fusion and 
differentiation in vitro is controversial. Touaitahuata and colleagues have argued that integrin 
signaling, assayed by podosome formation, is needed neither for fusion nor differentiation 
(Touaitahuata et al., 2013). Additionally, these same authors also concluded that podosomes 
are dispensable for OCs migration and, ultimately, differentiation (Touaitahuata et al., 2013). 
These findings are in contradiction with detailed molecular and imaging data provided by 
Oikawa and colleagues depicting a central role of podosomes in OC precursor fusion (Oikawa 
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et al., 2012). The data showed that podosome organization at the circumference of OC 
precursors maintains cell spreading and thus sustains the contact of plasma membranes of 
apposed cells during fusion. Oikawa and colleagues provided a molecular mechanism in 
which the scaffold protein Tks5, known for its role in podosome formation, is activated by 
phosphoinositide 3-kinase and Src kinase and thus promotes podosome-mediated cell-cell 
contact and fusion (Oikawa et al., 2012) 
In order to give rise to mature multinucleated cells in vivo, OC precursors need to migrate 
before making cell-cell contacts and finally fusing together. There is strong evidence pointing 
towards mononucleated precursor recruitment to the bone and formation of mature 
multinucleated OCs on the bone surface. What is unknown is whether in vivo the fusion 
occurs within the bone marrow (i.e. in a 3D context, before reaching the bone matrix) or after 
reaching the bone matrix (i.e. in a 2D context). If the first case is true, it would then be 
possible that OC precursors can dispense of podosomes even though, macrophages, which 
derive from the same OC precursors and also form podosomes, are capable of exhibiting 
podosome-like structures in a 3D matrix (Van Goethem et al., 2011). If the second case is 
true, podosome are likely to be important for migration and fusion because OCs precursors 
spontaneously make podosomes on bone and podosomes are the principal cytoskeletal 
structures that drive OC migration (Jurdic et al., 2006; Saltel et al., 2008).  
Finally, matrix receptors such as integrins are, in some cases, directly involved in cell-cell 
interaction (Ojakian et al., 2001). Hence, cell-cell contact is a factor that should be considered 
alongside adhesion and migration in order to better understand OC differentiation and fusion 
(Oikawa et al., 2012). In in vitro osteoclastogenesis assays, while low seeding densities of 
mononucleated precursors can challenge their migration by reducing the probability of 
passive cell-cell contacts, a relatively high density can trigger cell aggregation and, 
consequently, both surface expression of αVβ3 in these precursors (Boissy et al., 1998) as 
well as podosome-maintained membrane contacts (Oikawa et al., 2012). It would therefore be 
interesting to investigate the balance between matrix-dependent adhesion, cell-cell adhesion 
and migration on different substrates: adherent and non-adherent, 2D and 3D.  
 
 
 
As a result all the available stimuli and activated pathways that are required for their 
differentiation, OCs become giant multinucleated cells and acquire the proper molecular 
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arsenal allowing them to reach and degrade bone. How they use their arsenal to fulfill their 
destined function will the topic of the following section III. 
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III. PODOSOME ORGANIZATION IN OSTEOCLASTS 
 
 
At very early stages of their differentiation in vitro, OCs form integrin-based and actin-rich 
microscopic adhesive structures called podosomes. Although the existence of podosomes has 
not yet been demonstrated in vivo due to technological limitations of imaging methods, their 
formation in OCs seeded on their natural substrate, i.e. bone, has been documented by 
electronic microscopy and fluorescence microscopy (Luxenburg et al., 2007). Hence, their 
formation in vivo is highly plausible. Podosomes are circular structures that are around 1µm-
wide and that rise from the plasma membrane into the cytoplasm reaching a height of around 
0.6 µm (Destaing et al., 2003; Labernadie et al., 2010; Linder et al., 2011b) (Figures 9,10). 
They are essential for OC adhesion, spreading, migration and bone degradation. In fact, 
genetic depletions of their components or regulatory proteins in mice have serious 
consequences on the bone phenotype through disruption of OC structures.  
 
III.1. General principles of integrin activation  
Under cytokine stimulation, specific transcription factors activated in differentiating OCs 
stimulate the expression of proteins required for mature OC functions. Then, signals from 
cytokines and substrate simultaneously orchestrate the adhesive and cytoskeletal proteins into 
functional structures such as podosomes.  
Integrins undergo  large‐scale conformational  changes  in order  to attain a high‐affinity 
configuration  during  the  process  of  integrin  activation  (Paradise et al., 2011).  These 
receptors  are  currently  understood  to  exist  in  equilibrium  among  three  main 
conformational states (Figure 8).  In the  low‐affinity state,  the extracellular  leg domains 
are bent and the headpiece is closed, with an acute angle between the I‐like and hybrid 
domains. This conformation generally exhibits  little  to no binding  to biological  ligands 
but can bind to small RGD peptides in solution. In the high‐affinity conformation, the leg 
domains are extended and separated, and the headpiece  is open  (Paradise et al., 2011). 
The third conformation, with extended legs and a closed headpiece, is expected to be of 
intermediate affinity (Xiong et al., 2001; Takagi et al., 2002; Xiong et al., 2002; Paradise et 
al., 2011) (Figure 8). Although the “bent” state has a low binding affinity to RGD motifs in 
biological ligands, it is the physiologically dominant form, in particular in the presence of 
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Ca2+ and Mg2+ (Takagi et al., 2002; Paradise et al., 2011) and is sufficient for podosome 
formation (Faccio et al., 2002). However, both outside-in and inside-out signaling have been 
demonstrated capable of activation of the heterodimer (Takagi et al., 2002) (Figure 8). 
Indeed, the presence of MCSF, responsible for the inside-out activation of αVβ3 through the 
cytoplasmic tail of β3, can induce active αVβ3 enrichment at podosome sites (Faccio et al., 
2003a).  
 
 
 
Figure 8. Integrins exhibit three distinct conformations correlated with binding affinity. 
Headpiece domains are depicted in black. In the low affinity conformation, the integrin leg 
domains are bent and the headpiece is closed. In the intermediate affinity conformation, the 
leg domains are extended and the headpiece is closed. In the high affinity conformation the 
leg domains are extended, and the headpiece is open (Paradise et al., 2011). 
 
Importance of integrins in OCs has been realized through the extensive studies of αvβ3 
integrin and the matrix-degradation defects observed in Glanzmann patients or mice carrying 
null mutations in the β3 integrin gene (Gluckman et al., 1989; Hodivala-Dilke et al., 1999; 
McHugh et al., 2000). The reduced resorptive activity of β3-/- osteoclasts was thought to be 
caused by loss of αvb3-mediated signaling that regulates cell polarity and cytoskeletal 
reorganization (Faccio et al., 2003)  (Brunner et al., 2013). Likely, other integrin and 
specifically β1 integrins are also involved in osteoclast function. Indeed, a recent report using 
β1-deficient osteoclast point to an important role for this integrin family in the formation of 
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podosomes or invadopodia (Destaing et al., 2010; Schmidt et al., 2011). Some studies of 
integrin expression on osteoclasts show that αv, α2, β1, and β3 subunits are found in 
osteoclasts from human bone tissue (Nesbitt et al., 1993; Brunner et al., 2013). Deletion in 
mice of kindlin-3, an intracellular activator of integrins, leads to a severe osteoclast defect. 
This mimicks osteopetrosis observed in several patients with mutations in the Kindlin-3 gene, 
due to a block into their resorptive capacities (Schmidt et al., 2011). It has shown that loss of 
αv, β1, and β3 subunits, through kindlin-3 inactivation, ends up in a more severe osteopetrotic 
phenotype than β3 mutants alone. Most of the role of integrins in osteoclasts is seen through 
their implication in adhesion and resorption through podosome organization (Schmidt et al., 
2011). 
 
 
III.2. Recruitment of adhesion plaque molecules  
Besides integrins, other structural proteins are recruited to build the podosome. These proteins 
are described as cytoskeletal adaptors that organize F-actin. They are called collectively 
“plaque proteins”. One of these proteins is talin, which binds the cytodomain of β3 integtin 
subunit and also contributes to its inside-out activation (Calderwood, 2004; Paradise et al., 
2011; Zou et al., 2013). Talin is an elongated antiparallel flexible dimer (Winkler et al., 1997) 
capable of also binding F-actin and vinculin (Papagrigoriou et al., 2004). In turn, vinculin is 
able to bind F-actin, α-actinin and paxillin (Turner et al., 1990; Jockusch and Rudiger, 1996). 
The sequestration of these F-actin anchoring/docking proteins to several concentric integrin 
sites at the immediate vicinity of the plasma membrane, an interface usually called the 
“adhesion plaque”, indicates that podosome assembly/growth occurs in a bottom-up direction. 
Furthermore, the actin filaments anchored by these integrin-associated proteins are 
crosslinked by myosin II and α-actinin and organize into co-axial/radial segments linking 
concentric integrin sites (Luxenburg et al., 2007). This peripheral region of the podosome is 
collectively called the cloud. At the centre of the podosome, the F-actin network is 
characterized by a higher order of density called the “podosome core” (Figures 9,10).  
This high F-actin density in the podosome core is largely due to oriented and highly dynamic 
actin nucleation and branching machinery composed of cortactin (Wu and Parsons, 1993), the 
Arp2/3 complex, (Neuronal-)Wiskott Alrdich Syndrome Protein ((N-)WASP), WASP-
associated Protein (WIP) (Calle et al., 2004; Monypenny et al., 2011). The latter is necessary 
to the formation of the actin core for several reasons. First, WIP interacts and activates actin-
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organizing molecules (N)WASP, Nck and myosin (Krzewski et al., 2006; Anton et al., 2007; 
Monypenny et al., 2011). WIP also protects WASP from proteasomal degradation (de la 
Fuente et al., 2007). Second, by binding both to cortactin and actin monomers (G-actin), WIP 
recruits G-actin to cortactin-activated Arp2/3 nucleation sites proximal to the cytoplasmic 
membrane (Kinley et al., 2003) . The importance of WIP is visible through the cytoskeletal 
phenotype of WIP-/- murine OCs which produce podosomes that lack the core domain 
(Chabadel et al., 2007). Because WIP colocalizes with the podosome core, this phenotype 
provides experimental proof that the podosome cloud forms independently of the podosome 
core. 
 
III.3. The podosome subdomains  
III.3.1. The podosome core defined by CD44 
The study of WIP in OCs has underlined the importance of an unexpected podosome 
component: CD44.  CD44 is a cell-surface transmembrane proteoglycan that binds to 
hyaluronic acid, collagen, osteopontin and laminin (Goodison et al., 1999). The matrix-
dependent activation of CD44 can rescue podosome core formation in WIP-/- OCs and 
increases overall adhesion of these cells to their substrate. The need for outside-in activation 
of CD44 was additionally demonstrated by addition of activating antibodies and testing its 
podosome-rescuing capacity on different substrates (Chabadel et al., 2007). Surprisingly, 
inside-out activation of this receptor has not been investigated so far and the detailed 
mechanism used by CD44 to support podosome core formation remains unclear. The non-
overlapping localizations and functions of αVβ3 and CD44 served as decisive proof for the 
distinction between the two podosome domains: the cloud and the core.  
III.3.2. The podosome cloud defined by Src 
In parallel to the core-specific function of CD44, the tyrosine kinase Src has podosome-cloud 
specific function. In fact, the Src-/- OCs exhibit podosomes with cores but without clouds 
(Destaing et al., 2008). The SH2 or SH3 domains of Src are necessary for the docking of Src 
to the podosome cloud. This localization of Src can therefore allow it to exert its tyrosine 
kinase activity on podosomal proteins. Both the localization of Src and its enzymatic activity 
are essential for full podosome assembly (Destaing et al., 2008).  
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III.3.3. The podosome cap 
Finally, a novel podosomal subdomain has been reported: the podosome “cap”. The existence 
of this domain has been concluded from the localization of the formin FRL1 on top of the 
podosome core (Mersich et al., 2010; Linder et al., 2011a). Its potential role, however, is still 
to be elucidated.  
 
 
Figure 9. General schema of podosome architecture. The cloud subdomain of the 
podosome links the cell to the extracellular matrix (ECM) by integrins, and is contains F-actin 
(yellow) that is organized by adaptor (or plaque-type) proteins (like paxillin and talin) and 
crosslinked by myosin II. The core subdomain of the podosome is linked to the ECM via 
CD44 and contains dense network of branched actin (red). The cap subdomain rests on top of 
the F-actin dome of the core. Its function is not yet characterized (Linder et al., 2011a). 
 
III.4. Uncertainty about spatio-temporal order of podosome formation 
The exact spatio-temporal order of recruitment of proteins to the site of nascent podosomes 
has not been fully dissected. In consequence, the chronological priority of cloud versus core 
formation during normal podosome assembly is still debated. A study made by Luxenburg 
and colleagues, however, suggested that the first step of podosome assembly is the 
recruitment of cloud-component paxillin followed by core-component cortactin (Luxenburg et 
al., 2012b). This step, which represents the formation of the adhesion plaque at the 
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membrane-cytosol interface, is followed by the apparition of F-actin at the podosome core 
simultaneously with recruitment of α-actinin. β3 integrin would then be recruited to the 
podosome site. Although this data consolidates some aspects of the current podosome 
formation model, such as down-to-up assembly and inside-out activation of integrins, it raises 
a serious question: how are the site and the direction of actin nucleation in the core 
determined in the absence of integrins? A part of the answer could lie in the fact that, besides 
β3, other integrins subunits, such as αV, β1 and β2 and other non-integrin receptors such as 
CD44 are present at podosome site (Chabadel et al., 2007; Schmidt et al., 2011). These 
receptors, which have not been kinetically accounted for, can therefore participate in initial 
docking of the adhesion plaque and F-actin.  
 
 
 
 
 
Figure 10. Model depicting the interplay of actin network and myosin IIA at podosomes. 
The amount of core and ring components in existing podosomes ﬂuctuates, reﬂecting their 
variable protruding activity over time. Paxillin and talin are already present at their maximum 
levels in small podosome cores. As a reaction to matrix rigidity, podosomes grow vertically 
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by actin polymerization at the base of the core, tension is generated within the actin network 
and transmitted to talin and paxillin, thereby further driving the recruitment of the tension-
sensitive vinculin and zyxin to reinforce the podosome and facilitate its protrusive activity. 
The connection of the actin network to the ring most likely occurs through talin and vinculin, 
whereas the main players crosslinking the network ﬁlaments to the core are still unknown. 
Myosin IIA cross-links the actin network ﬁlaments and is essential for core shrinkage by 
either generating contractility or directly unbundling and depolymerizing the actin network, 
thereby inducing podosome core instability. The delicate balance between actin 
polymerization in the core and myosin IIA activity in the ring facilitates core oscillations  (van 
den Dries et al., 2013b).  
 
III.5.  Podosome internal dynamics: interplay between polymerization and 
contractility 
 
Once the podosome is “constructed”, it has a lifespan of several minutes (2-10minutes). This 
seemingly long duration is however coupled with highly dynamic modulation, which is owed 
to intrinsic physical properties of its molecules.  
First, the scaffold of the podosome, i.e. F-actin, is a polymer that constitutively undergoes fast 
treadmilling (Wanger et al., 1985) and is entirely renewed every 20 to 60 seconds in OC 
podosomes, i.e. at least 2.5 times within the podosome lifespan (Destaing et al., 2003). This 
fast actin turnover requires the presence of polymerization regulating molecules such as 
gelsolin. This protein is in fact an actin-capping and -severing protein with cleaves fast 
growing filament ends and thus creates new nucleation sites (Yin et al., 1981; Southwick, 
2000). Gelsolin localization at podosomes has been extensively documented (Zallone et al., 
1983; Marchisio et al., 1984; Duong et al., 2000) and its indispensability to podosome 
formation in OCs has been confirmed (Chellaiah et al., 2000a) (Figure 11). Moreover, 
gelsolin depletion in mice results in mild osteopetrosis (Chellaiah et al., 2000a). The presence 
of cofilin, another actin-severing protein at podosome sites has been recently described 
(Blangy et al., 2012; Touaitahuata et al., 2013). Cofilin is characterized with a lower affinity 
for actin compared to gelsolin (Southwick, 2000) but how it regulates podosomes is still 
unknown. 
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A second level of podosome dynamics is provided by acto-myosin contractility (Chabadel et 
al., 2007) and elastic properties of vinculin and talin (Turner et al., 1990) all present in the 
podosome cloud. These molecules convey to podosomes a property called 
“mechanosensitivity”, which can be defined by modulation of contractility in parallel to F-
actin polymerization in the core and, therefore, the adaptation of size and stiffness of the 
entire podosome to the extracellular matrix (Labernadie et al., 2010; van den Dries et al., 
2013b) (Figure 10). Mathematical modeling of gelsolin-mediated actin polymerization in 
podosomes has predicted that F-actin growth can itself be a size-limiting factor of podosome 
core growth (Hu et al., 2011a) (Figure 11). It is therefore conceivable that contractility and 
actin polymerization can interdependently modulate podosome mechanosensitivity.  
 
 
 
 
Figure 11. Schema of a mathematical model depicting steady-state actin turnover in the 
podosome. For simplification purposes, the model is considered as consisting of 2 dynamics 
elements: actin and gelsolin. Actin polymerization takes place at the base of the podosome 
core (with a diameter = σ) by recruitment of actin monomers at a characteristic speed v. After 
reaching an inherent limit of height, these polymers are severed by gelsolin thus releasing 
smaller polymers into the podosome cloud. In the cloud, gelsolin (diffusion rate  = Dg) 
cleaves again the small polymers (diffusion rate = Dn) at a defined severing rate β (Hu et al., 
2011a).  
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III.6. OC-specific podosome properties 
Podosomes are not exclusively present in OCs. Different cell types from a variety of lineages 
also exhibit these cytoskeletal structures. They include endothelial cells (Moreau et al., 2003), 
smooth muscle cells (Kaverina et al., 2003) and cells from the monocytic lineage such as DCs 
and macrophages (Linder et al., 1999; Calle et al., 2006). The fact that podosome-presenting 
cells have different physiological functions shows the high adaptability of podosomes to 
different microenvironments. Although the pool of structural proteins that builds the 
podosome is conserved between different cell types, the signals that transduce podosome 
formation are often different. It is therefore not surprising that some experimental 
observations depict differences between podosomes in different cells. This section will review 
some of these differences within the monocytic lineage, in other words between podosomes of 
OCs, DCs, and macrophages.  
First, given that dynamic actin polymerization and depolymerization are necessary to 
maintain all podosomes, the genetic ablation of gelsolin, a high-affinity actin-severing protein 
that promotes actin turnover, in OCs results in their inability to form podosomes and SZs 
(Chellaiah et al., 2000a) but has visibly no effect on podosome formation in DCs 
(Hammarfjord et al., 2011). Second, several studies of podosomes of mature OCs seeded on 
culture-treated glass collectively evolve into circular patterns called rings and SZ-like 
structures (Jurdic et al., 2006). In human and murine macrophages seeded on 2D substrates, 
podosomes also collectively organize into circular structures called “rosettes”  (Cougoule et 
al., 2012). In DCs however, podosomes do not exhibit such circular distributions but rather 
sustain their individual aspect  (van den Dries et al., 2013b). Third, cell migration has been 
shown to be mainly exerted by podosome rings in OCs. These observations suggest that there 
are yet unrevealed molecular pathways that induce the collective circular patterning of 
podosomes in OCs and in macrophage. A subset of such pathways could be exclusive to OCs 
to adequately support bone resorption through SZ formation. Furthermore, the role of WIP to 
integral podosome formation seems to be more indispensable to DCs compared to OCs. WIP-
/- DCs do not exhibit podosomes at all (Banon-Rodriguez et al., 2011) whilst Wip-/- OCs do 
form podosome clouds (i.e. podosomes without the core) although overall podosome 
formation is decreased compared to wildtype OCs (Chabadel et al., 2007).  
Interplay between the actin-containing podosomes and other components of the cytoskeleton, 
such as microtubules, can also be differently regulated between cells. Whilst chemical 
microtubule depolymerization (with nocodazole) severely abolishes podosome formation in 
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macrophages (Linder et al., 2000), treatment with the same chemical at higher concentrations 
only partially blocks podosome formation in OCs but dramatically abrogates their collective 
patterning (Destaing et al., 2005).  
Finally, how podosomes dynamics and patterning could be regulated in an OC-specific 
manner is yet unknown. Interestingly, studies of Rho-Rock signaling in OC and OC-like cells 
(Ory et al., 2000; Chabadel et al., 2007)  (reviewed in (Ory et al., 2008b)) have shown that 
this pathway can temporally regulate podosome patterning during osteoclastogenesis and in a 
substrate-dependent manner. Signaling upstream of Rho and downstream of Rock though 
remain unclear. 
 
 
III.7. Podosome patterning in osteoclasts 
III.7.1. Structural and kinetic properties 
Regardless of the debated importance of podosomes and adhesion in general to the OC 
differentiation process itself, these structures are undoubtedly crucial for the support of the 
mature function of OCs: bone resorption. As early as individual podosomes form within an 
OC, they are collectively and sequentially organized into patterns along the life of the same 
cell. These patterns evolve from apparently random groups of podosomes called “clusters” to 
circle of podosomes “rings” and, eventually to more massive circular structures, i.e. either 
“sealing zones” (SZ) or “SZ-like structures” (SZL, also known as “belts”) (Destaing et al., 
2003; Saltel et al., 2004; Jurdic et al., 2006; Luxenburg et al., 2007) (Figure 12).  
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Figure 12. Current model of dynamic podosome patterning in OCs. Podosomes 
(surrounded by red dotted line) are collectively arranged into clusters the rings then finally 
either sealing zones (SZ) or SZ-like structures (also called “belts”). In the cluster, podosomes 
are grouped in close vicity as can be seen by immunofluorescence (IF) in a region of the cell 
and have a “relaxed” architecture as shown in the scanning electron micrograph (SEM). As 
podosomes transition from clusters to rings, transient cicrular patterns. Finally, rings can 
transform into SZs, if the osteoclast is seeded on bone or into SZ-like structures if the 
osteoclast is seeded on a non-mineralized substrate. The SZ ensures proper bone resorption by 
confining the degradation molecules secreted by the OC ruffled border into the resorption 
lacuna. The SZ-like structure is not associated with a functional activity and is at the extreme 
periphery of the cell. Note the increase in podosome density and interconnectivity in the SZ 
and the SZL compared to the cluster. Kinetic, biochemical and structural properties that 
accompany the patterning process are also displayed in this scheme: the pattern life span 
(grey), the increasing (green) and decreasing (red) factors (Adapted from (Luxenburg et al., 
2007; Saltel et al., 2008; Novack and Faccio, 2011)). 
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The first pattern formed by a group of podosomes is the cluster. Several clusters can exist 
within an OC. At this point, individual podosomes have a “relaxed” conformation: the 
diameter of the core is ~300 nm, that of the cloud is 3µm and the average distance between 
the cores of two podosomes is 750nm (Luxenburg et al., 2007). Podosomes being in this 
vicinity, the radial F-actin filaments of neighboring podosome clouds overlap in a common 
region yet without directly linking the cores to each other, suggesting the existence of some 
topological crosstalk between podosomes (Luxenburg et al., 2007). The cluster pattern can 
last up to several hours in an OC while the lifespan of an individual podosome within the 
cluster is around 3 min (Destaing et al., 2003; Luxenburg et al., 2006a) (Figure 12). This 
means that podosome patterns are sustained by spatial commitment of de novo podosome 
formation through yet unknown mechanisms. Several non-exclusive hypotheses could explain 
this spatial confinement: (1) a local abundance of matrix-embedded or membrane-anchored 
molecules that directly stimulate podosome formation; (2) a wider microenvironment-induced 
cell-homing mechanism that induces migration or resorption in a given direction; (3) a 
cytoplasmic enrichment of podosomal proteins “left over” from disassembled podosomes thus 
shifting the balance from a diffusion-rate stochastic podosome formation anywhere at the cell-
matrix interface in the favor of the region containing previous component. 
As clusters grow, de novo podosomes are positioned towards the periphery of the clusters thus 
making transient circular structures that lasts for a few minutes: the rings (Figure 12). 
Although individual podosomes within a given pattern are not displaced, it has been 
suggested that, as a consequence of actin nucleation and polymerization at the base of the 
podosome core, nascent podosome repel each other while growing (Hu et al., 2011a). The 
lifespan of individual podosomes in rings shortens down from 3 min to 1 min (Luxenburg et 
al., 2006c), thus conveying a more dynamic aspect to this pattern compared to clusters 
(Figure 12). The shorter podosome lifespan is correlated with a fast ring expansion rate at 2 
µm/s (Destaing et al., 2003). A more detailed characterization of ring properties has been 
technically challenging because of the transient nature of this structure. However, what is 
visible by microscopy of fluorescently labeled actin is that if rings stabilize, i.e. exceed their 
typical lifespan without changing that of individual podosomes (Luxenburg et al., 2006c), 
rings can give rise either to the SZ or to the SZL. When OCs are adherent to a non-
mineralized substrate (glass, plastic), rings are transformed into SZL by fusing together and 
positioning podosomes at the very periphery of the OC (Luxenburg et al., 2007). When OCs 
are on bone or on dentine, rings give rize to SZs by growing individually and making a 
thicker and more central and stable “super-ring” (D. Georgess, unpublished data).  
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The SZ and SZL are the most mature podosome patterns. The role of the SZ is to ensure 
osteoclastic bone resorption by confining OC-secreted degradation molecules at the vicinity 
of the bone matrix (see Section IV: Bone resorption processes). Its formation is substrate-
exclusive, meaning that the SZ forms only on mineralized substrates such as bone or 
hydroxyapatite-coated glass (Saltel et al., 2004). The SZL is thought to be the equivalent of 
the SZ that forms only on non-mineralized substrates such as culture-treated plastic or glass. 
Hence, the SZL is not affiliated with a specific function like the SZ, but it is used as an easier 
model to gather biochemical and microscopical data on collective podosome patterning in 
mature OCs.  
The overall transition from clusters to SZs is marked not only by a collective displacement of 
podosomes but also by different internal actin dynamics and increased interconnectivity 
between podosomes (Figure 12). The amounts of actin and other structural proteins such as 
paxillin, vinculin and α-actinin recruited per podosome increases 3- to 4-fold in this 
transitions and neighboring podosomes become more tightly packed with a core-to-core 
distance that increases 2-fold on average, reaching 480 nm in the SZL and 210 nm in the SZ 
(Luxenburg et al., 2007). With the increase of intimacy between podosomes, the density of 
the F-actin radial fibers that make the podosome cloud increases (Figure 12). This allows for 
clouds to form a continuous circular band with a thickness of 2-3 µm in the SZL and 3-6 µm 
in the SZ. The podosome cloud is therefore “accorded” 70 to 80 % of all the actin present in 
the podosome (with 20-30% of podosomal actin in the core) knowing that, at the cluster stage, 
the cloud only contained about 30% of actin present in the podosome (Luxenburg et al., 
2012a).  
Although the rate of actin turnover might change from one pattern to another, it has been 
shown that individual actin turnover rates in the cloud and in the ring are similar and vary 
simultaneously (Destaing et al., 2003). Even if these two podosomal subdomains might have 
different molecular architectures, the joint actin turnover rate attests for a common regulation 
of actin polymerization. 
 
Finally, although all the mentioned podosomal patterns can appear within the lifetime of a 
single OC, the frequency of their formation varies as a function of OC maturation. In the early 
stages of osteoclastogenesis, the cluster is the most frequent pattern, making around 65% of 
all patterns. At the final stages of OC maturation, the SZL becomes the major pattern, 
constituting more than 60% of all patterns in OCs (Destaing et al., 2003). This observation 
reveals that OCs, in order to organize these patterns, not only respond to instantaneous 
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extracellular cues but also commit very early along their differentiation to end-line functions 
such as resorption by reaching mature podosomal patterns. The fact that this differential 
patterning frequency occurs on the same substrate makes it tempting to speculate that the 
long-term regulation is directly dependent on genetic factors. Given that the frequency of SZL 
patterns coincides with increase OC fusion events, it would be interesting to investigate 
whether multinucleation is a direct genetic determinant of SZ formation. 
 
III.7.2. Molecular mechanisms implicated in patterning  
Podosome patterning is a complex molecular process that requires spatio-temporal regulation 
of signals and effector molecules. The molecular pathways that govern patterning were totally 
mysterious a decade ago but are now starting to be elucidated.  
Tyrosine protein kinases: Src 
During the collective patterning of scattered podosomes into the SZ/SZL, the apparent 
amount of certain structural proteins such as actin, vinculin, cortactin, α-actinin and paxillin 
increase within the individual podosome. The increase of these proteins is inversely correlated 
with global tyrosine phosphorylation in podosomes (Luxenburg et al., 2006b; Luxenburg et 
al., 2012a). This residue-specific post-translational modification has been associated with 
dynamic changes in adhesion structures. However, data on tyrosine kinases in OCs, albeit 
very revealing when available, is scarce.  
In OCs, Src localizes to podosomes and is important for their assembly as well as their 
patterning (Destaing et al., 2008). The dual importance of Src involves structural/docking 
activity and kinase activity. The first is necessary for the proper formation of the actin cloud 
in podosomes probably by binding the cytoplasmic tail of β3 and Pyk2 at the same time (Zou 
et al., 2007; Destaing et al., 2008). Interestingly, although Src kinase activity has also been 
shown important for podosome initiation, it is most crucial for rearrangement of podosomes 
by phosphorylating several downstream targets (Destaing et al., 2008). Src can activate 
another tyrosine kinase Syk, which is involved in podosomal rearrangement by facilitating 
Rac GTPase activation (Faccio et al., 2005). Indeed, mice lacking Src, Syk, or vav3 
expression suffer from increased bone bass due to defective OC-resorption (Soriano et al., 
1991; Horne et al., 1992; Lowell and Soriano, 1996; Faccio et al., 2005). Another target of 
Src is cortactin, which induces slow actin turnover in podosomes in its phosphorylated form 
and thus contributes to SZL formation (Martinez-Quiles et al., 2004; Luxenburg et al., 
2006c). Finally, Src expression, has been shown to increase during osteoclastogenesis 
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(Verollet et al., 2013) thus suggesting that it is needed for mature podosome patterns. When 
other tyrosine kinases that are important for podosome patterning such as Hck are deleted, 
OCs compensate for this deletion by overexpressing Src which in fact re-establishes mature 
podosome patterning, i.e. SZL formation, and above-average OC resorptive capacity. 
However, Src is not expressed in OC precursors and therefore its overexpression cannot 
rescue defected precursor migration towards bone. As a result, Hck-/- mice, despite 
overexpressing Src in OCs, are ostepetrotic (Verollet et al., 2013). 
 
Rho GTPases 
This family of molecular switches mediates signal transduction and cytoskeletal remodeling 
related to a broad spectrum of cellular processes in all cell types (Vega and Ridley, 2008; 
Hall, 2012). These molecules have been extensively studied in vitro and in vivo but the 
specificity of the OC cytoskeleton raises the difficulty in extrapolating their roles of into OCs. 
The comprehension of the roles of these proteins has been coincidently further complicated 
by several technical difficulties encountered by investigators as will be briefly discussed in 
the following paragraphs. 
•  Rho  
The importance of Rho to podosome organization and OC-mediated bone resorption has first 
been commented by Zhang and colleagues. In their study, the microinjection of C3 
exoenzyme (a Clostridium botulinum toxin which inhibits RhoA/B/C) in murine OC-like cells 
resulted in the disassembly of the SZL structure after 20 min (Zhang et al., 1995). The 
treatment of avian OCs with C3 lead, in the first 15 min, to transient growth of podosomes but 
eventually resulted in their complete dissolution 2 h after the treatment (Chellaiah et al., 
2000b). Also, avian macrophage polykaryons treated with TAT-C3 conjugated to the HIV 
TAT peptide (that ensure cell penetration) suffered from total podosomes disassembly (Ory et 
al., 2000). This data shows a positive contribution of Rho to podosome stability. However, 
when the reversed experiments were performed, i.e. when avian OCs were transduced using a 
constitutively active Rho, they also suffered from podosome disassembly after 30 min 
(Chellaiah et al., 2000b). The converging results of Rho overactivation and inhibition suggest 
the necessity for a precise and time-dependent Rho activation levels during podosome 
formation and patterning. 
Even more, a discrepancy is observed between the C3-meditated podosome disassembly in 
avian macrophage polykaryons and C3-mediated stabilization of podosome rings and SZ 
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disassembly (Ory et al., 2000; Destaing et al., 2005). Whether this experimental contradiction 
is species-dependent and/or due to technical differences should be investigated.  
Finally, the SZL-stabilizing role of Rho is dependent on the decrease of its GTPase activity 
during OC maturation. Indeed, lower levels of active Rho allow for less activation of its 
effector, mDia. In fact, active mDia can activate HDAC6 and thus lead to deactetylation and 
destabilization of microtubules (MTs). Therefore, lower levels of Rho allow for the 
stabilization of MTs by maintaining their acetylation, resulting in enhanced OC spreading and 
SZL formation at the cell periphery (Destaing et al., 2005).  
•  Rac  
Rac1 and Rac2 are both expressed in OCs. These proteins are generally involved in 
organization of the cytoskeleton and are also important components of the NADPH, the 
enzyme that generates free radicals. The NADPH-related function of Rac has not been related 
with podosome organization.  
A study of Rac functions in OCs using a murine Cre-recombinase-based genetic depletion 
model has depicted distinct roles of each of the two Rac proteins during OC precursor 
chemotaxis and differentiation in vivo (Wang et al., 2008). This study has been contested by 
another group claiming the insufficient depletion of Rac1 and Rac2 genes in the first study 
(Croke et al., 2011). In the more recent study, it is shown that Rac1 and Rac2 are not involved 
in osteoclastogenesis but have overlapping roles in podosome assembly and SZL formation 
by localizing Arp3 at podosome sites during osteoclastogenesis. The Rac double knockout 
therefore results in podosome disassembly, the absence of SZs and diminished bone 
resorption but only if Rac deletion occurs at early OC precursor stage. The abnormalities first 
observed in OCs due to Rac double knockout, strangely, were not reproduced when Rac 
deletion was driven by a different promoter corresponding to Cathepsin-K+ differentiating 
OCs. As the cathepsin-K promoter activity is specific to committed OCs, it is thought that the 
absence of effect under this promoter is due to the incorporation of much less committed, 
upstream mononucleated precursors where Rac1/ 2 are not deleted (Croke et al., 2011). The 
importance of Rac1/2 to the OC cytoskeleton and bone resorption is, however, confirmed by 
targeting them via intra-cellular blocking antibodies (Razzouk et al., 1999).  
Rac activity in OCs is regulated by its Guanine nucleotide Exchange Factors (GEFs) Dock5 
and vav3 (Faccio et al., 2005; Vives et al., 2011b). Dock5 is increasingly expressed along 
osteoclastogenesis and localizes to podosomes in SZLs. The deletion of Dock5 in mice results 
in an osteopetrotic phenotype explained by decreased Rac activity, absence of podosome 
formation and SZL patterning leading to reduced adhesion and bone resorption (Vives et al., 
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2011b). Distinctly from Dock5, the other Rac-specific GEF in OCs, vav3 is stably expressed 
during osteoclastogenesis but, like Dock5, promotes cell spreading and SZ formation (Faccio 
et al., 2005). Physiologically, Vav3-null mice are osteopetrotic and protected from PTH- and 
RANK-stimulated bone loss indicating a role of this GEF in physiologically regulated bone 
remodeling. 
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IV. BONE RESORPTION PROCESSES 
 
 
IV.1. Transmigration 
At the latest stages of their differentiation/maturation, OCs are multinucleated giant cells with 
one main task: to resorb bone. In order to accomplish this function, the OCs needs to move to 
adequate regions of the bone and several possible hurdles can stand in its way. Because the in 
vivo trajectory undertaken by the OC to reach the bone surface is still uncertain, attempts have 
been made to better assess the tissue invasion potential of the OC by recreating the 
multicomponent bone microenvironment in vitro.  
The surface of bone is largely covered by osteoblasts, bone-lining cells and, in some 
pathological situations, fibroblast-like cells (Pap et al., 2003) and metastatic cells (Zhao et al., 
2006). These cells are able to secrete chemokines that attract OCs and locally promote bone 
degradation. At the same time, these cells can proliferate and/or differentiate abundantly in 
the vicinity of bone, thus representing a barrier between the OC and its resorption destination. 
OCs, similarly to highly invasive metastatic cells, express high levels of Src and Matrix 
Metalloproteiases (MMPs) (Yu et al., 2003) are able to, first, transmigrate through such cells 
layers by forming large actin rich protrusions and, second, to spread over matrix and 
underneath the invaded cells (Figure 13) (Saltel et al., 2006). The actin rich protrusion 
observed in transmigrating OCs reaches a diameter of at least 5µm (Figure 13) and therefore 
seems bigger than podosome-like structures observed in 3D-migrating macrophages (Van 
Goethem et al., 2010) and invadopodia observed in metastatic cells (Linder, 2007). but could 
share similarities with the latter such as degradation-mediated invasion. Indeed, the chemical 
inhibition of either Src or MMPs hampers the transmigration process (Saltel et al., 2006).  
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Figure 13. Model of osteoclast transmigration through cell layers. Multinucleated mature 
osteoclasts seeded on top of osteoblast layers (A) rapidly extend actin-rich protrusions 
through the stromal layer (B) until they contact the underlying substrate (C) on which they 
spread (D). Micrographs in insets: (*) show actin (red) and integrin β3 (green) in X/Y 
sections at the level indicated by black dotted lines. Left inset in (B) is a 3D reconstruction of 
the protrusion, bars: 5µm (Saltel et al., 2006). 
 
IV.2. Bone degradation: trafficking, acidification, proteolysis 
Once it reaches the bone matrix, the fully differentiated OC can start resorbing bone. In order 
to fulfill its task, the OC become polarized and its membrane is reorganized into four distinct 
and unique membrane domains: the SZ, the ruffled border (RB), the basolateral domain (BL) 
and the functional secrectory domain (FSD) (Figures 14,15) (Salo et al., 1996; Coxon and 
Taylor, 2008a). The RB is the resorptive organelle of the OC. Its function is to acidify the 
subjacent resorption lacuna therefore dissolving the mineral phase of the bone and to secrete 
proteases that will degrade the organic phase of the bone (Coxon and Taylor, 2008a). The RB 
is a convoluted membrane with a high surface area that forms as a consequence of active and 
directed transport of vesicles that fuse with the plasma membrane in the basal pole of the OC, 
facing the bone matrix (Abu-Amer et al., 1997; Mulari et al., 2003a; Mulari et al., 2003b). In 
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fact, late endosomes/lysosomes originating from the BM are acidified by V-ATPases which 
pump protons into the lumen of vesicles. In parallel to this acidification, chloride channels 
such as ClC-7 transports chloride ions into the lumen to maintain the electroneutrality of the 
vesicles (Coxon and Taylor, 2008a). Along with acidification, the RD-delivered lysosomes 
are also responsible for the trafficking of proteolytic enzymes to the resorption lacuna. The 
cysteine protease Cathepsin-K, which is specific to OCs and most efficient in degrading type I 
collagen, is also delivered to the RB via acidic late endosomes/lysosomes (Zaidi et al., 2001; 
Zhao and Vaananen, 2006). The matrix metalloprotease-9 (MMP-9) also contributes to the 
lysosome-mediated bone degradation but is activity is presumably specific to certain site of 
the bone tissue (Everts et al., 1992). This vectoral lysosome trafficking is dependent on 
prenylated Rab GTPases (Feng et al., 1995; Bucci et al., 2000) and mediated by via dynein 
anchorage to MTs (Jordens et al., 2001). This dynamic transport of lysosome results in their 
delivery to the peripheral region of the RB, close to the SZ. The liberated acidic content upon 
fusion with the RB membrane allows therefore the liberation of protons that dissolve the 
mineral phase of the bone but also ensure acidic pH, optimal for Cathepsin-K activity (Zaidi 
et al., 2001). Conversely, in the central region of the RB, the degraded matrix components are 
collected by clathrin-mediated endocytosis and trafficked via the transcytosis pathway to the 
FSB where they are excreted to the blood stream (Salo et al., 1997; Hirvonen et al., 2013) 
(Figure 15). Hence, the central region of the RB is called the “Uptake Zone”. Interestingly, 
another osteoclastic protease, tartrate resistant acid phosphatase (TRAP), has not been found 
to be transported to the RB via the already described late endocytic pathway. The delivery of 
TRAP is therefore suggested to be part of the biosynthetic-secretory pathway, which, like the 
endocytic pathway, is derived from the Golgi apparatus (Vaaraniemi et al., 2004) (Figure 15). 
Additionally, TRAP is also thought to be present in non-acidic biosynthetic vesicles that fuse 
with transcytotic (Vaaraniemi et al., 2004). Because cathepsin-K can activate the phosphatase 
activity of TRAP by cleavage of its two subunits (Ljusberg et al., 2005), the role of TRAP 
might be to further process collagen fragments inside transcytotic vesicles before their 
liberation through the FSD (Coxon and Taylor, 2008a). Finally, a new pathway called 
“Reverse Transcytosis” that consists of delivering vesicles from the FSD to the peripheral 
zone of the RB, thus compensating for the membrane loss during the matrix uptake process 
(Vaaraniemi et al., 2004) (Figure 14).  
It is hypothesized that first event of OC polarization is SZ formation (Coxon and Taylor, 
2008a) probably because the polarization does not occur on non-mineralized substrates, where 
the OC has a completely flat morphology (sign of the absence of polarization) and forms a 
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SZL instead of a SZ (Saltel et al., 2004). Adding further support to this hypothesis is the 
conceptual argument stating that RB formation and activity, i.e. secretion of degradation 
molecules, would be a waste of the cell’s resources if the confinement of these molecules in 
the immediate vicinity to the bone surface were not ensured. However, the publication of few 
studies suggesting that protease secretion by OC is independent of polarization (Henriksen et 
al., 2006; Hollberg et al., 2008) or that morphological differences exist between OC at 
different bone sites highlight that there is still much to be learned about OC polarization 
during bone resorption.  
 
 
 
Figure 14. Transmission electron micrograph of a bone resorbing human osteoclast. The 
rufﬂed border (localised between the white arrows) penetrates deep into the bone matrix. An 
area of translucent vacuolar structures is visible directly adjacent to the rufﬂed border inside 
of the cell (indicated by the long black arrows). Numerous vacuolar (v) structures are also 
visible close to the basolateral plasma membrane; secretory-type vacuoles are also abundant 
(ﬁlled arrowhead). N: nucleus. (Stenbeck, 2002). 
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Figure 15. Vesicular trafﬁcking pathways in osteoclasts. The rufﬂed border is formed as a 
consequence of trafﬁcking of vesicles in the endosomal pathway, and therefore has 
characteristics of a late endosomal membrane. A distinct biosynthetic pathway may also 
contribute to the formation of the rufﬂed border. Degradation products from the resorption 
process are removed from the resorption lacuna by a transcytotic path- way and released at 
the FSD, which exhibits characteristics of an apical membrane. Recently, a reverse pathway 
from the FSD to the rufﬂed border has been identiﬁed. FSD, functional secretory domain; BL, 
basolateral domain; SZ, sealing zone (Coxon and Taylor, 2008a). 
 
IV.3. The resorption-migration cycle   
While adherent on the bone surface, the OC needs to search for news spots to degrade. It is 
thought that its migration is driven by podosomes because of their role in migration of other 
cells such as macrophages (Linder and Kopp, 2005) but a mechanism depicting how 
podosomes exactly promote this 2D displacement during resorption is yet to be provided. One 
plausible hypothesis assumes that cyclic podosome switching between two categories of 
patterns, the SZ-state and a non-SZ state (i.e. cluster or ring), allows the OC to alternate 
between bone resorption and motility, respectively (Saltel et al., 2008; Novack and Faccio, 
2011). This model is derived from two in vitro observations: (1) the SZ, which is the 
podosomal arrangement that is maintained during bone degradation, stays in a relatively 
(basal domain) 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stable position; (2) the “resorption tracks” made by OC cultured on bone, dentine, ivory and 
hydroxyapatite slices consist of several individual resorption lacunae that overlap to make 
form of what could be described as a “chain” or also a trail of partially overlapping pits 
(Figure 16).   
If this model were true, the OC would have to undergo fast transitioning also between two 
different directions of polarization. While migrating, the OC should be horizontally polarized, 
i.e. parallel to the substrate and with a leading edge and a trailing edge. While resorbing, the 
OC should be vertically polarized, in order to degrade the matrix and export its components to 
the systemic blood stream. 
     
 
 
Figure 16. The osteoclast resorption-migration model. (A) Scanning electron micrograph 
of a resorbing osteoclast on dentine showing consecutive and partially overlapping circular 
resorption pits/lacunae (dotted yellow circles). (B) Resorption tracks of osteoclasts seeded on 
dentine, then removed for the staining of resorption tracks with Toluidine blue, again showing 
overlapping circular resorption pits/lacunae (small dotted yellow circles) (Susa et al., 2004). 
(C) Schematic representation of the current working model that depict OC-switching between 
Basal pole 
Apical pole 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an apico-basal-like polarization and an antero-posterior polarization during resorption and 
migration, respectively. Schema in (C) is adapted from (Novack and Faccio, 2011). 
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CHAPTER 2: RESULTS 
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I. OC MIGRATION 
 
I.1.  Introduction and rationale: How do podosomes drive OC migration?  
OCs are adherent and motile cells. During their migration, they form dynamic multimolecular 
adhesive structures called podosomes, which are not only characterized by internal turnover, 
but also by collective patterning from clusters to rings. Because podosomes bridge (a) the cell 
to (b) its substratum, we investigated whether these structures had a particular role in 
mediating the mechanical interplay between the two elements (a and b). In other words, are 
podosomes the cause or the consequence of cell adhesion and displacement? 
The cell-matrix relationship is continuous but involves several different processes: adhesion, 
spreading and, migration. Our broad question was therefore divided into several distinct parts 
to obtain experimental insight into each of these processes.  
 
Timelapse micrographs of OCs in culture have shown that these large cells, as soon as they 
contact the matrix, first need to spread and, once properly spread, they start migrating in a 
given direction. We therefore first inspected the timing of podosome formation during the 
initiation of cell spreading and cell retraction using fluorescence and Nomarski contrast 
microscopy. By detaching and reseeding OCs, we observed that the OC first adheres then 
starts exhibiting podosomes concomitantly with its spreading. Inversely, the inhibition of 
integrin-mediated adhesion in already spread OCs resulted in podosome disassembly before 
subsequent cell retraction and detachment. These results indicated that podosomes are needed 
for maintaining adhesion during spreading but are not the exclusive mediators of these 
processes. Podosome exert forces to initiate and maintain the spreading of the OC.  
We also sought to identify the leading podosome patterns during these sequential events.  We 
found that podosome ring expansion is what initiates and maintains OC migration.  
 
During the migration phase per se, we aimed at a qualitative description of the short-term 
forces exerted by the cell on the matrix and of the typical OC migration trajectory. To this 
end, we imaged short-term podosome ring movement on a fluorescently labeled substrate. We 
could therefore correlate the outward expansion of the podosome ring to the displacement of 
the substrate and we concluded that podosome rings exert on the substrate the tension needed 
for cell displacement.  
  70
Finally, we described the typical long-term OC migration trajectory and quantified 
displacement parameters in the perspective of establishing a physical correlation between the 
cell and its actin cytoskeleton. The displacement of the cellular actin mass always preceded 
the global cell displacement by a characteristic lag time, demonstrating once again that the 
actin-based structures are at the basis of OC movement. Moreover, the ring-dependent 
trajectory was characterized by periodic lateral “jumps” resulting from asymmetrical stability 
of rings in the migrating OC.  
 
Finally, the mechanical data obtained from this study, combined with previously 
demonstrated data on podosome dynamics, allowed us to form a working model that governs 
OC motility. The model elaborates that podosomes grow in close vicinity during assembly on 
a confined area, such as the area of a cluster or a ring. Hence, because of a steric frustration 
event that accompanies their growth, podosomes repel each other and create the tension 
needed for migration. 
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I.2. Publication: Podosome rings drive saltatory osteoclast migration 
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II. NOVEL REGULATORS OF BONE RESORPTION: FOCUS ON RHOE 
 
 
II.1. Introduction and rationale: Finding new regulators of the actin cytoskeleton in 
osteoclast-mediated bone resorption       
 
Ring-driven migration and SZ formation are essential to OC-mediated bone resorption. 
Podosomes are the structural units of the ring and the SZ but the molecular signaling that 
governs their collective organization into these superstructures remains elusive. In this study, 
our goal was to find new genes that would be relevant to this OC-exclusive functional 
patterning. The investigation was therefore comprised of two main parts:  
 
We first aimed at finding a new list of candidate genes possibly involved in cytoskeletal 
processes during bone resorption. Such a list would be considered as grounds for selection for 
functional investigation of individual genes. To that end, we established an original 
comparative model that takes advantage of the differentiation plasticity of monocytic lineage 
cells. Since OCs are multinucleated cells derived from the differentiation and fusion of 
mononucleated monocytic precursors, we differentiated the same precursors into another type 
of multinucleated giant cells (MGCs) that shares several OC traits. These MGC formed 
podosomes and expressed osteoclastic degradation enzymes, but were unable to resorb. Based 
on these phenotypical properties, we used Affymetrix Genechip technology to perform a 
transcriptome-wide comparison between OCs and their non-resorbing counterparts with the 
objective of sorting out the genes that are exclusively expressed in OCs. We therefore 
obtained a list of genes that were highly expressed in OC. We validated this list using the 
Taqman Low Density Array, a method of highthroughput qPCR that provided more reliable 
quantification of gene expression levels. At each of these two screening steps, we observed a 
significant enrichment of actin-regulating genes, most of which where not studied in OCs. 
This reinforced the importance of the actin cytoskeleton for OC function and suggested new 
possible regulators for it. We therefore chose to functionally investigate RhoE because it is a 
constitutively active GTP-binding protein that was previously shown to regulate actin-based 
structures such as focal adhesions and stress fibers. 
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Using primary culture of OCs derived from a RhoEgt/gt (knockout by gene trap) mouse, we 
observed that this gene was dispensable for OC differentiation but essential to bone 
resorption.  Given its previously described actin-regulatory functions in other cells, we 
hypothesized that its role in bone resorption could be played via regulation of the OC 
cytoskeleton. Using confocal microscopy and Fluorescence Recovery After Photobleaching, 
we showed that RhoE expression maintains fast actin turnover in podosome clusters and rings 
and therefore regulates their patterning. Consequently, RhoE-deficient OCs suffered from 
impaired migration and suboptimal SZ formation, two crucial processes for bone resorption. 
Finally, we proposed a molecular pathway accounting for the participation of this gene to 
actin remodeling in OC podosomes: in wildtype OCs, RhoE inhibits Rock-mediated 
phosphorylation of a recently identified podosomal component: cofilin. The reduced levels of 
non-phosphorylated cofilin, the active form of this protein, would therefore ensure fast actin 
turnover in podosomes and ultimately facilitate their patterning.  
 
Altogether, the data provided in this study depict a new role for RhoE in the control of actin 
dynamics in podosomes through Rock-antagonism. It also provides a new molecular link 
between podosome patterning in OCs and bone resorption.  
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II.2. Publication: Comparative transcriptomics reveals RhoE as a novel regulator of 
bone resoption by OCs  
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ABBREVIATIONS 
BM: bone marrow 
OC(s): osteoclast(s) 
DC(s): immature dendritic cell(s) 
DC-MGC(s): multinucleated giant cell(s) derived from dendritic cells, not including OCs 
DC-17-MGC(s): multinucleated giant cell(s) derived from dendritic cells by stimulation with 
IL-17 
DC-17 γ -MGC(s): multinucleated giant cell(s) derived from dendritic cells by stimulation 
with IL-17 and IFN-γ 
DC-OC: dendritic-cell derived osteoclast 
FL: Foetal liver 
FRAP: Fluorescence recovery after photobleaching 
IL-17: interleukin-17 
IFN-γ: interferon-γ 
M-CSF: macrophage colony stimulating factor 
MGC(s): multinucleated giant cell(s) 
Mo: monocytes 
Mo-OC: monocyte-derived osteoclast 
RANKL: receptor activator of nuclear factor κB 
SZ: sealing zone 
TRAP: tartrate-resistant acid phosphatase 
gt: gene trap 
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Abstract 
Osteoclasts (OCs) are multinucleated giant cells (MGCs) of the monocytic lineage, 
responsible for bone resorption. Podosomes are actin-rich adhesive structures important for 
OC functions because they pattern into “rings”, that drive osteoclast migration, and into 
“sealing-zones” (SZs) that ensure optimal enzyme and proton confinement in the resorption 
lacuna. Although changes in actin dynamics during podosome patterning have been 
documented, the mechanisms that regulate these changes are largely unknown. From human 
monocytic precursors, we differentiated MGCs that express OC degradation enzymes, but are 
unable to resorb the mineral matrix. We demonstrated that, despite exhibiting bona fide 
podosomes, these cells presented dysfunctional SZs. We then performed two-step differential 
transcriptomic profiling of bone resorbing OCs versus non resorbing MGCs to generate a list 
of genes implicated in bone resorption. Among the generated list of candidate genes, we 
investigated the role of RhoE/Rnd3. Using primary RhoE-deficient OCs, we demonstrated 
that RhoE is indispensable for OC migration and bone resorption. Using FRAP analysis, we 
found that RhoE is required for maintaining fast actin turnover in podosomes probably by 
inhibiting Rock-dependent cofilin phosphorylation. Consequently, the role of RhoE in 
podosome dynamics is central for OC migration and SZ formation and therefore to bone 
resorption. 
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INTRODUCTION 
 
OCs are giant multinucleated cells (MGCs) of the monocytic lineage that are responsible for 
bone resorption. They differentiate and fuse from mononucleated precursors such as 
monocytes (Mo) or immature dendritic cells (DCs) in the presence of receptor activator of 
nuclear factor κB ligand (RANKL) and macrophage colony stimulating factor (M-CSF) 
(Rivollier et al., 2004; Speziani et al., 2007; Boyce, 2013). Once differentiated, mature OCs 
resorb the bone matrix by secreting protons and proteases, such as tartrate-resistant acidic 
phosphatase (TRAP), cathepsin-K and matrix metalloprotease 9 (MMP9) onto the underlying 
bone matrix. A circular adhesive superstructure called “sealing zone” (SZ) allows these 
molecules to be within the resorption pit (lacuna) for efficient bone degradation.  
Other types of MGCs can be also generated from immature DCs under various conditions. 
DCs stimulated by interleukin-17 (ll-17), potentiated by IFN-γ, leads to DC-17γ-MGCs 
(Coury et al., 2008). Besides resulting from cell-cell fusion of the same precursors (i.e. DCs), 
DC-17γ-MGCs have OC-like characteristics namely the expression of bone-degrading 
proteases such as TRAP, MMP9 and Cathepsin-K (Coury et al., 2008) as well as forming 
adhesive structures called “podosomes” (Olsson Akefeldt et al., 2013).  
Podosomes are integrin-based actin-rich dot-like structures, which are present in OCs, DCs 
and macrophages (Linder and Kopp, 2005). They are the structural units of OC SZ 
(Luxenburg et al., 2007). A model of intra-podosomal architecture in monocytic cells that is 
currently widely accepted depicts two distinct domains within podosomes: a peripheral 
domain made of a loose F-actin meshwork with adhesion and adaptor molecules like αVβ3 
integrin, paxillin, vinculin, myosin II, and a central domain comprised of a tightly connected 
F-actin network with adaptor molecules like cortactin and Arp2/3 (Linder and Aepfelbacher, 
2003; Chabadel et al., 2007). When formed in OCs, podosomes are first assembled in clusters 
that self-organize into “rings” and finally into SZs on mineralized substrates or into “SZ-like” 
structures (also known as “podosome belts”) on non-mineralized substrates. Besides driving 
the saltatory migration typical of OCs, podosome rings have been described as short-lived 
patterns, with life spans of 10-15 minutes, that mediate the transition from clusters to SZ–like 
patterns, more stable structures with life spans of several hours (Destaing et al., 2003; Saltel 
et al., 2004; Jurdic et al., 2006). Interestingly, the life span of individual podosomes decreases 
by at least two folds with the transition from clusters to rings/SZ-like structures indicating 
differential regulation during podosome “remodeling” (Luxenburg et al., 2007). The 
regulation of podosome assembly and disassembly as well as their inner architecture and 
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stability are of central importance to their patterning. Therefore, fast and dynamic 
polymerization and depolymerization of actin, the scaffold of podosomes, has to be tightly 
regulated in OCs. For example, knockout of gelsolin, a high-affinity actin severing and 
capping protein, results in the inability of OCs to form podosomes (Chellaiah et al., 2000a). 
In the same context, slowing the rate of actin turnover in OCs using cytochalasin D, an actin 
capping molecule, leads to overstabilized podosomes with longer life spans and seemingly 
larger podosome cores (Luxenburg et al., 2012b). Another important mechanism that 
regulates podosome size, stability and patterning is acto-myosin-II contractility around 
podosome cores (Meddens et al., 2013).  
Some studies have provided data as to how these processes are regulated at the molecular 
level in OCs. Src has been shown as an indispensable regulator of phosphorylation of 
podosomal proteins such as cortactin and gelsolin (Luxenburg et al., 2006b; Destaing et al., 
2008). Control of podosome patterning by small GTPases, namely RhoA and Rac1/2 in OCs 
has been well documented. Rac activation following integrin-dependent signaling is essential 
to form a functional SZ. Indeed, mice lacking both Rac1 and Rac2 display massive 
osteopetrosis due to the inability of OCs to form SZs and subsequently resorb bone (Croke et 
al., 2011). Supporting this result, deletion of Rac GTPase Exchange Factors (GEFs) Vav3 and 
Dock5 in mice also present osteopetrotic phenotypes explained by an osteoclast functional 
defect (Faccio et al., 2005; Vives et al., 2011a). RhoA is critical for maintaining OC 
polarization and SZ formation on a mineralized matrix (Chellaiah et al., 2000b; Destaing et 
al., 2005). The complete molecular scheme of actin cytoskeleton regulation in OCs that is 
needed to adequately support bone resorption is still largely incomplete. Studies of Rho-Rock 
signaling in OC and OC-like cells have shown that this pathway can temporally regulate 
podosome arrangement during osteoclastogenesis and in a substrate-dependent manner but 
Rock-downstream signaling in OC remains unclear (Chellaiah et al., 2000b; Ory et al., 2000; 
Ory et al., 2008a). 
In this study, we aimed at finding new genes implicated in actin-related control of bone 
resorption by OCs, we have compared transcriptomic profiles of human primary Mo-derived 
OCs (Mo-OCs) and DC-derived OCs (DC-OCs), on one side, with those of Mo, DCs and DC-
17 γ -MGC(s) with OC-like traits, on the other, to find genes that were highly upregulated in 
mature OCs. As a result, we obtained a short list of actin-regulating genes that were up 
regulated in mature OCs, considered as candidates for functional studies. We focused on the 
role of one candidate, RhoE (also known as Rnd3), in bone resorption using a genetic 
knockout model. Given its already described function in other actin structures such as focal 
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adhesions and stress fibers, we investigated its implication in OC podosome-related aspects 
such as size, actin dynamics, patterning and cell migration. Finally, given that RhoE 
interaction with Rock-I has been widely shown to be a central pathway of RhoE function 
(Riento et al., 2003; Riento et al., 2005), we checked whether RhoE function in OCs was 
Rock-dependent.  
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RESULTS 
 
 
Non-resorbing human multinucleated giant cells exhibit osteoclast-like characteristics 
but are unable to resorb bone. 
Knowing that DC-17γ-MGCs are multinucleated giant cells expressing OC degradation 
markers such as TRAP, cathepsin-K and MMP9, we first asked whether they were able to 
resorb the mineral matrix in comparison with bone-resorbing DC-OCs. Then, we investigated 
their actin containing adhesion structures. Initially differentiated on tissue culture dishes, 
mature DC-OCs and mature DC-17γ-MGCs on day 5 and 13 of culture, respectively, were 
detached and seeded on apatite-collagen complexes (ACC), a bone-mimicking substrate 
(Shibutani et al., 2000; Saltel et al., 2004), and stimulated with M-CSF and RANKL to 
promote resorption. Confocal microscopy of these cells fixed and stained for actin showed, as 
expected, that DC-OCs exhibited circular actin-rich sealing zone (SZs) and were able to 
resorb the mineralized matrix. DC-17γ-MGCs, however, were unable to resorb the matrix and 
displayed circular actin structures that were significantly less frequent and smaller in size 
compared to OC SZs (Figure 1A,B). We therefore named the latter actin structures 
"dysfunctional SZs" because of their inability to ensure proper degradation of the mineral 
matrix. 
To gain further insight into cytoskeletal organization in DC-17γ-MGCs, we compared their 
actin organization with that of human Mo-OCs and DC-OCs on glass. We labeled these cells 
for actin, cortactin, a component of the podosome core as well as for paxillin and vinculin, 
components of the podosome cloud. We acquired images with a confocal microscope and 
visualized protein colocalization of one podosome marker at a time with actin by displaying 
channel merges and pixel-to-pixel multiplication of normalized and non-saturated 
micrographs. We found that cortactin colocalized perfectly with actin in podosome cores of 
Mo-OCs, DC-OCs as well as in DC-γ17-MGCs. Vinculin and paxillin also colocalized with 
actin in podosome clouds in all three cell types (Figure 2). These results showed that DC-
17γMGCs, albeit displaying bona fide podosomes, are unable to efficiently organize SZs, 
which may participate to their inability to resorb bone.  
 
Comparative transcriptomics revealed bone resorbing OC-specific genes  
In order to identify new genes involved in osteoclast-mediated bone resorption, excluding 
ones involved in myeloid cell-cell fusion, we performed transcriptomic profiling of human 
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bone resorbing Mo-OCs, DC-OCs as well as their precursor cells, Mo and DCs, and non-
resorbing DC-derived MGCs. These latter MGCs included DC-17-MGC(s) and DC-17γ-
MGCs (Figure 3A). Practically, blood monocytes from healthy human donors were 
differentiated in either DCs with M-CSF and IL4, or OCs with M-CSF and RANKL. DCs 
were then further differentiated in OCs (DC-OCs) with M-CSF and RANKL or DC-17γ-
MGCs with IL17 and INF- γ. Total RNAs were extracted from these six culture conditions for 
two to four independent healthy donors and separately analyzed analyzed by GeneChip® 
Microarray technology by using 54675 distinct probes. Given the high number of probe sets 
used, a gene was considered as expressed in a cell type if its mean expression was superior to 
the overall gene expression in the same cell type (see Mat and Methods). This allowed us to 
establish a differential list of 115 genes that were expressed only in OCs (Figures 3, S1, S2). 
The presence in this list of RNAs for NFACT1, the OC-specific transcription factor 
(Takayanagi, 2007) (reviewed in (Takayanagi et al., 2002a)) and ATP6v1c1, a proton pump 
needed for OC podosome ring formation (Feng et al., 2009), validated our approach. Both 
resorbing and non-resorbing group of cells were maintained in cell fusion culture conditions, 
consequently any genes known for roles in cell-cell fusion (such as DC-STAMP, ATP6v0d2, 
or OSCAR) were eliminated from this analysis. We therefore considered these 115 genes as 
new potential candidates for the investigation of OC functions. The “molecular functions” of 
this list compared to the human genome as determined by Gene Ontology (GO) vocabulary 
underlined enrichment in “Cytoskeletal protein binding” and its sub-category “Actin binding” 
(Figure 3B).  
We aimed at further validating candidates that would be preferentially involved in 
cytoskeletal regulation of bone resorption as opposed to genes rather implicated in other OC 
mechanisms. DC-17γ-MGCs were used as MGCs reference model. We then determined RNA 
expression values of the previously identified 115 genes in Mo-OCs, DC-OCs, DC-17γ-
MGCs and their Mo and DC precursors by Taqman Low Density Array (TLDA), a high 
throughput quantitative real-time PCR. We then averaged the mean expression of a gene (Xc) 
from several human blood donors and determined if Xc was significantly higher in both Mo- 
and DC-OCs compared to non-resorbing Mo, DCs and DC-17γ-MGCs by using the limma 
test. This method allowed us to spot 6 genes that were highly expressed in OCs (marked in 
red in Figure 3A), but were not even detected in the other cells types, namely TM4SF1, PLS3 
(also known as T-fimbrin), ARHE (also known as RHOE or RND3), LNX1, AK5 and 
MYO1B. Three out of these six genes (PLS3, MYO1B and RHOE) have been already 
described as regulators of actin structures in several cell types whereas PLS3 protein has been 
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shown as a component of podosomes in Mo-OCs (Babb 1997 Cell Motility and 
Cytoskeleton). Given the importance of Rho-GTPases in the regulation of podosomes in OCs, 
we aimed at further investigating RhoE role in OCs. 
 
RhoE is essential for bone resorption but not for OC differentiation 
RhoE has been previously shown as a regulator of focal adhesions and stress fibers in 
different cell types. We first investigated the implication of RhoE in osteoclastogenesis using 
primary murine precursors isolated from a RhoE genetrap mouse model (Mocholi et al., 
2011). Because these animals rarely surviving 15 after birth, we used either fetal liver (FL) or 
P14 bone marrow as a source of OC precursors. We differentiated primary OCs from fetal 
liver (FL) precursors from RhoE+/+, RhoE+/gt and RhoEgt/gt E15.5 littermates in the presence of 
M-CSF and RANKL on culture-treated dishes and on cortical bone slices. Differentiation of 
FL-derived OCs (FL-OCs) on days 5, 6 and 8 post seeding was assayed by TRAP staining. 
On both substrates, no difference in the number of TRAP-positive cells with 3 or more nuclei 
were observed between these different genotypes (Figure 4A). In the same assay, we also 
counted the number of nuclei per OC on days 5 and 8 of culture on plastic wells as a measure 
of OC precursor fusion (Figure 4B). Again, we observed no difference in the absence of 
RhoE expression. We therefore concluded that RhoE does not play a role in 
osteoclastogenesis.  
To evaluate the role of RhoE in OC-mediated bone resorption, we performed resorption 
assays in two different conditions. First, precursors from RhoE+/+ and RhoEgt/gt littermates 
were differentiated directly on cortical bone slices. On day 8 of differentiation, the cultures 
were stopped and the resorption index was determined from surface area measurement of 
toluidine blue-positive resorption pits and TRAP staining of OCs on the same slices. RhoEgt/gt 
OCs resorbed bone about 25 times less than wildtype OCs (Figure 4C, upper panel). In the 
second condition, we detached day-4 RhoE+/+ and RhoEgt/gt FL-derived OCs (FL-OCs) that 
were initially differentiated on culture-treated plates and seeded them for 48h on OsteoAssay 
substrate (OAS) plates, a bone-mimicking substrate. We counted the number of TRAP-
positive OCs per well and, in replicate wells, quantified the total resorbed area per well with 
Silver Nitrate staining. Hence, we calculated the mean resorption index per OC. Again, 
RhoEgt/gt OCs resorbed the OAS matrix about 12 times less than RhoE+/+ OCs (Figure 4C, 
lower panel). These results accounted for an essential role of RhoE in bone resorption in vitro.  
 
Small SZs and actin based defective structures in RhoE-lacking  OCs  
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RhoE has been involved in the control of actin cytoskeleton in other cell types (Guasch et al., 
1998). We therefore investigated its role in SZ formation, given the critical importance of this 
actin structure in the bone resorption process. Day-4 FL-OCs expressing or not RhoE were 
lifted from culture-treated plates and seeded for 24h on bone slices. These OCs were then 
fixed, stained for actin and imaged using confocal microscopy. Using ImageJ software, 
peripheral outlines of SZs were then manually determined from acquired micrographs 
allowing the quantification of the surface areas of SZs. There was a slight yet significant 15% 
decrease in mean SZ size in RhoEgt/gt OCs compared to RhoE+/+ OCs (Figure 5). This result 
indicated that RhoE expression was dispensable for SZ formation but was needed to maintain 
normal SZ size.  
Because of the observed effect of RhoE knockdown on SZ size, we investigated its 
importance for podosome formation and patterning into cluster, ring and SZ-like 
superstructures. Fixed day-4 BM-derived OCs (BM-OCs) were stained with fluorescently 
labeled phalloidin and imaged with confocal microscopy. Based on observed local 
fluorescence intensity, actin staining of OC allowed not only the identification of individual 
podosomes within an OC but also the discrimination between the two subdomains of 
podosomes: the core with high fluorescence intensity and the cloud with low intensity 
according to (Chabadel et al., 2007) and (van den Dries et al., 2013c) (Figure 6A). We 
therefore applied a method of fast and curated fluorescence intensity-based quantification of 
podosome core surface area. Briefly, once OC cell periphery was drawn manually, we used 
the "Find Peaks" plugin of ImageJ software with a set of fixed parameters (see Material and 
Methods) to count podosome numbers per cell and the size of individual podosome cores. We 
found that the mean number of podosomes per OC was decreased in RhoEgt/gt OCs 
(645podosomes/cell) compared to RhoE+/+ OCs (1018 podosome/cell). Podosome core size 
was, however, increased in the absence of RhoE expression as shown by mean values and 
frequency distribution of size (Figure 6B). This suggested that RhoE is not necessary for 
initial podosomes formation but is important for maintaining proper podosome size. 
We then, quantified the number of OCs with clusters, rings and SZ-like structures per well. 
The total number on average per well of OC exhibiting these podosomal structures was 
significantly decreased in RhoEgt/gt OCs (45 per well) compared to RhoE+/+ OCs (75 per well) 
whilst the mean OC number per well was not altered as previously shown by the TRAP assay. 
In more detail, the mean number of OC with clusters was decreased from 20 per well in 
wildtype cultures to 10 per well in RhoEgt/gt and SZ-like structures from 47 per well to 21 per 
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well, in that same order. The number of OC with rings was however increased up to 14 per 
well in RhoEgt/gt OCs compared to 6 per well for wildtype OCs (Figure 6C).  
Combining these data with the results from podosome size and number assays suggested that, 
as a result of RhoE depletion, podosomes were bigger therefore unusually stable but their 
number was insufficient to properly form clusters. This increase in podosome stability was 
also depicted by the enrichment in rings, normally transient structures required for SZ-like 
formation, resulting in fewer SZ-like counts per well. We concluded that RhoE is required for 
podosome organization and patterning. 
 
RhoE controls actin turnover in podosome clusters and rings  
The abnormalities of podosome size, number, superstructure patterning and OC-mediated 
bone resorption observed in RhoEgt/gt OCs raised the question of RhoE effect on actin 
turnover in podosomes. To address this point, we performed FRAP experiments on actin in 
podosome rings and clusters of day-5 FL-OCs 48h after their infection with a LifeAct-
mCherry-coding lentivirus to label actin (Figure 7A). We fitted relative fluorescence intensity 
data with a non-exponential equation of recovery (Negi and Olson, 2006) to minimize 
constraints by mathematical functions (such as exponential growth). In wildtype OCs, mean 
actin turnover half times in clusters and rings were 9.8 sec ± 1.4 and 19.7sec ± 3.5, 
respectively. This showed that rings normally exhibit slower actin turnover.  These values 
were significantly increased in RhoEgt/gt OC for both structures: 24 sec ± 3 in clusters and 
34.4 sec ± 3.8in rings (Figure 7B). These data indicated that RhoE is involved in maintaining 
a fast actin turnover in podosomes.  
 
Depletion of RhoE results in impaired OC migration 
Having demonstrated a role of RhoE in actin dynamics in podosomes and in podosome 
stability and patterning, we hypothesized that RhoE would be implicated in OC migration. To 
test this hypothesis, we performed a random migration assay on OC. Differentiating FL-OCs 
expressing or not RhoE were detached on day 4 of culture and replated on culture-treated 
dishes at identical low confluence (5x104 cells per well) to minimize OC fusion events. 
Timelapse movies were then acquired with phase-contrast microscopy and randomly 
migrating OCs were manually tracked. As visualized in single OC migration tracks (Figure 
8A), wildtype OCs displayed typical saltatory migration consisting of displacement in a 
straightforward direction followed by a recognizable angular turn as we had published in a 
previous study (Hu et al). This pattern of migration allowed OCs to randomly cover a large 
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surface area. RhoEgt/gt OCs displayed aberrant migration tracks where they turned in circles 
because of frequent consecutive angular turns to one side (Figure 8A). The frequency 
distribution of the instantaneous angle change (Δαi) of several wildtype OC migration tracks 
nicely fitted a Gaussian distribution (R2 = 0.91) in which the amplitude, indicating the 
frequency of straightforward movement (i.e. when Δαi is close to 0°), was 2.85% ± 0.07 and 
the absolute standard deviation (SD, i.e. the interval containing the most frequent 34% single-
sided angle changes close to the mean) of 68.4° ± 2.01. Interestingly, values from RhoE
gt/gt 
OCs deviated from the Gaussian distribution (R2 = 0.58) with an amplitude of 1.97% ± 0.08 
and an absolute standard deviation of 115° ± 6.51. The mean of Δαi Gaussian distributions did 
not vary between the two genotypes (-2.35° ±1,99 for RhoE+/+ OCs and -8.76° ± 5.31 for 
RhoEgt/gt OCs) because we pooled in our quantification several individual tracks which had 
negative or positive Δαi values. However, amplitudes and SDs were significantly different 
denoting a decrease of the frequency of straightforward displacements and the increase of the 
frequency of angular turns during OCs migration in the absence of RhoE expression. This 
aberrant distribution of angle changes therefore resulted in a significantly lower instantaneous 
persistence of RhoEgt/gt OCs (Pi=0.335) compared to that of RhoE
+/+ OCs, (Pi = 0.419) 
(Figure 8B). Additionally, quantification of the instantaneous velocity of displacement (Vi) 
showed a significant decrease from 0.86 µm/sec ± 0.01 in RhoE+/+ OCs to 0.57 µm/sec ± 0.38 
in RhoEgt/gt OCs (Figure 8B). These data showed that RhoE plays an essential role in the 
directionality as well as velocity of OC migration.  
 
RhoE inhibits Rock−mediated cofilin phosphorylation 
Having shown a role of RhoE in podosome dynamics and organization, we sought to find its 
subcellular localization and the molecular mechanism through which RhoE could perform this 
function.  Day-5 BM-OCs overexpressing RhoE-GFP were fixed, stained with phalloidin and 
imaged with a confocal microscope. Interestingly, RhoE did not colocalize with podosomes 
per se but was rather ubiquitous in the cytoplasm with certain enrichments at membrane 
borders (Figure 9A). We therefore considered that RhoE probably acts indirectly on actin in 
podosomes.  
It has been shown for focal adhesions and stress fibers that RhoE acts on the actin 
cytoskeleton through its inhibition of Rock-I kinase activity. Hence, we searched in mature 
OCs, phosphorylation targets downstream of Rock-I, such as Mypt1, a regulator of myosin-II 
(Van den Dries), and cofilin, that could mediate the effects of RhoE on podosome size and 
actin dynamics. We blocked Rock kinase activity in day-5 BM-OCs for 2h using an inhibitor, 
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Y-27632, and probed by immunoblotting of total lysates the canonical phosphorylation sites 
of each of the two Rock targets: cofilin phosphorylation on serine 3 and Mypt1 
phosphorylation on threonine 696 (Figure S3). We observed a decrease in p(Ser3)-Cofilin but 
not p(Th696)-Mypt1 ratios normalized to their respective total protein controls. Thus we 
validated cofilin as a downstream target of Rock in mature OCs.  
Then, to investigate whether cofilin phosphorylation was altered in the absence of RhoE 
expression in a Rock-dependent manner, we probed p(Ser3)-cofilin levels in RhoE+/+ and 
RhoEgt/gt BM-OCs with or without inhibition of Rock activity by Y-27632. In the absence of 
Y-27632 treatment, p(Ser3)-cofilin was 2.3 times higher in OCs lacking RhoE expression 
than in wild type OCs. The addition of Y-27632 reduced cofilin in both situations whilst 
Rock-I levels did not vary in any of these conditions (Figure 9B) suggesting that the observed 
changes in cofilin phosphorylation were independent of Rock-I expression levels but 
dependent on its kinase activity. Taken together, these experiments revealed that, when 
expressed in OCs, RhoE partially blocks Rock-mediated cofilin phosphorylation and therefore 
the presence of active i.e. non-phosphorylated cofilin.  
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DISCUSSION 
 
Actin organization during podosomes patterning is central for osteoclast migration and bone 
resorption. In order to further decipher the mechanisms involved in actin remodeling in bone 
resorbing osteoclasts, we took advantage of human monocytic plasticity. Indeed, we are able 
to generate, from human blood cells, either two types of OCs derived from Mo or from DCs 
(Rivollier et al., 2004), or two different types of MGCs derived from DCs (Coury et al., 2008 
and unpublished data). Characterization of DC-derived MGCs, revealed that, despite 
expressing osteoclastic proteases (Coury et al., 2008), they were unable to resorb the mineral 
matrix. Moreover, their actin cytoskeleton was organized into circular superstructures 
reminiscent of SZs that were named “dysfunctional SZs” because of their inability to ensure 
resorption of a mineralized matrix in comparison with OC SZs. We have showed that, in 
MGCs, vinculin, as previously reported (Olsson Akefeldt et al., 2013), but also cortactin and 
paxillin perfectly colocalize with actin in podosomes. This indicated that the existence of 
bona fide podosomes in DC-derived MGCs is insufficient for SZ formation and, more 
importantly, it suggested that there are yet unknown SZ-specific molecular regulations which 
are absent in non-patterned individual podosomes. 
A Comparative transcriptomics analysis between the two bone resorbing OC populations 
versus the two MGCs allowed us to provide a list of 115 genes that were highly expressed in 
OCs but not in MGCs. We hypothesized that these genes would be relevant to mature 
osteoclast functions. Among these, we validated six genes that were highly and exclusively 
expressed in OCs, namely TM4SF1, AK5, LNX1, MYO1B, RHOE/ARHE/RND3 and 
PLS3/T-PLASTIN/T-FIMBRIN. Previous studies have provided data linking these genes 
either with OCs and/or with the actin cytoskeleton. PLS3, a member of the fimbrin family, 
has been shown to colocalize with OC podosomes (Babb et al., 1997). AK5 expression is 
stimulated by RANKL in osteosarcoma cells (Mori et al., 2007). TM4SF1, a member of the 
tetraspanin family described for their interaction with integrins at the cell surface, is involved 
in nanopodia formation and cell migration (Zukauskas et al., 2011). LNX1 is responsible for 
the ubiquitinilation of Src, a known   OC regulator (Weiss et al., 2007). Myo1B, a member of 
the myosin superfamily, is localized in filopodia in HeLa and Cos-7 cells (Almeida et al., 
2011) and regulates Arp2/3 in Golgi-related actin foci. Finally, RhoE, a constitutively active 
RhoGTPase, inhibits stress fibers and focal adhesions by inhibiting the Rho-Rock pathway. 
Considering the importance of Rho signaling pathways in OCs (Zou and Teitelbaum, 2010), 
we focused our interest on RhoE.  
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RhoE depletion did not affect primary OC differentiation nor fusion but greatly decreased 
bone resorption. RhoEgt/gt OCs were still able to form podosomes but those were fewer in 
numbers per cell and with smaller cores compared to RhoE+/+ OCs. FRAP experiments 
targeting actin in podosomes revealed a significantly slower actin turnover in clusters and 
rings of RhoE deficient OCs. Such an increase in podosome stability and core size in OCs has 
been observed when actin turnover rate was reduced with cytochalasin-D treatment 
(Luxenburg et al., 2012a). Furthermore, lack of RhoE expression resulted in smaller SZs in 
OCs seeded on bone. Besides RhoE, RhoA is also dispensable for podosome formation but 
required for their patterning and SZ spreading (Chellaiah et al., 2003; Destaing et al., 2005). 
However, conversely to the results of RhoE knockdown, the chemical inhibition of Rho 
resulted in the spreading of SZ to a belt at the cell periphery of OCs seeded on ACC (Saltel et 
al., 2004). The reversed consequences of RhoA and RhoE inhibitions suggest antagonistic 
functions of these proteins in OCs.  
The increase in the number of OCs with rings provoked us to investigate typical ring-driven 
saltatory OC migration in the RhoE-depleted OCs. We have previously described OC random 
migration as a long phase of movement in the same direction followed by a short phase 
consisting of a 90°-switch in direction (Hu et al., 2011b). In the herein study, we provide new 
quantifiable parameters of migration demonstrating that it is considerably altered in RhoEgt/gt 
OCs, namely by a decrease in displacement velocity and an increase in the frequency of 90°-
angle turns. This resulted in global loss of persistence of OC movement. These observations 
make it tempting to speculate that slow actin turnover rate in rings causes increase in rings 
stability and results in impaired migration and SZ organization. 
To find the molecular pathway in which RhoE could take part to modulate actin kinetics in 
OCs, we investigated downstream phosphorylation targets of a well-described RhoE partner, 
Rock-I (Riento et al., 2003). Contrary to its upstream activator Rho (Chellaiah et al., 2000b; 
Ory et al., 2008a), Rock-I downstream signaling towards podosomes has been poorly studied. 
However, in non-myeloid cells, RhoE direct binding in 1:1 complex dimers, inhibits kinase 
activity of Rock-I, but not of its isoform Rock-II, 
(Komander et al., 2008). This Rock-I-RhoE interaction destabilizes actin-based focal 
adhesions and stress fibers when RhoE is over expressed (Klein and Aplin, 2009). We 
investigated two known Rock-I phosphorylation targets, namely Mypt1 and cofilin. Mypt1 is 
the main subunit of the myosin light chain phosphatase (MLCP) that activates acto-myosin-II 
contractility (Ito et al., 2004). We asked if Mypt1 was a Rock-I target in OCs and could 
explain a myosin-II-dependent regulation of podosome size and patterning as suggested in 
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previous studies (van den Dries et al., 2013a) (Luxenburg et al., 2012b) (Linder and Kopp, 
2005). The chemical inhibition of Rock activity revealed that Mypt1 phosphorylation status at 
its primary phosphorylation site is not Rock-dependent in OCs. Similarly, when myosin-II 
contractility was blocked in OCs, the size and stability of clustered podosomes were not 
affected (Luxenburg et al., 2012b). On the other hand, cofilin is an actin severing and capping 
protein that regulates F-actin assembly and disassembly thus promoting fast actin turnover 
(Lappalainen and Drubin, 1997; Maekawa et al., 1999). Non-phosphorylated cofilin has been 
shown as the active form whilst its phosphorylation on Serine 3 blocks its activity (Arber et 
al., 1998) (Abe et al., 1996). Furthermore, both total and phosphorylated cofilin have been 
already shown to localize at podosome clusters and SZ-like structures but how they regulates 
these structures was still unknown (Blangy et al., 2012; Touaitahuata et al., 2013). We did not 
investigate gelsolin, another actin-severing molecule, because gelsolin-/- OCs, contrarily to 
RhoEgt/gt OCs, are totally unable to form podosomes (Chellaiah et al., 2000a).  This drastic 
effect of gelsolin depletion on the cytoskeletal phenotype of OCs is probably due to its much 
higher affinity to actin compared with cofilin (Ressad et al., 1998; Southwick, 2000). This 
suggests that gelsolin is likely to be implicated in podosome formation rather than their 
patterning. Inhibition of Rock severely reduced cofilin phosphorylation at serine 3. We found 
that p(Ser3)-cofilin levels in RhoEgt/gt OCs were much higher than in RhoE+/+ OCs. RhoE 
could therefore be responsible for the inhibition of Rock-mediated cofilin inactivation, thus 
ensuring fast actin turnover in OCs. 
This Rock-RhoE-cofilin pathway highlights once again the importance of actin cytoskeleton 
organization in mature OC processes implicated in bone resorption such as migration and 
sealing zone formation. It also consolidates the emerging model that dissociates podosome 
dynamics from OC adhesion (Hu et al., 2011b) and differentiation (Touaitahuata et al., 2013). 
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MATERIALS AND METHODS 
 
Ethics Statements  
All animal procedures were approved by local ethics comitee for animal welfare of the 
Universidad CEU Cardenal Herrera, ID#CEBA03/2007,met the local guidelines, European 
regulations (EUdirective86/609) and standards for Use of Laboratory Animals nu 5388-01 
(NIH).  
 
Primary human cell cultures 
All the human cell types used in this study were differentiated directly or indirectly from 
peripheral monocytes from healthy donor blood (Etablissement Français du Sang, Lyon 
Gerland, France). All the human recombinant cytokines used for human cultures were 
obtained from Peprotech (USA). Briefly, CD14+ Mo were isolated from blood after two 
successive gradient centrifugations in Leukocyte Separation Medium (CMSMSL01-01, 
Eurobio, France) and 50% Percoll (Gallois et al., 2010), respectively, followed by negative 
antibody selection. CD14+ CD16+ Mo were then differentiated into OCs in α-minimal 
essential medium (α-MEM) (22561, Life Technologies, USA) with 10% fetal bovine serum 
(Bio West, France), 100units/ml Penicillin, 100µg/ml Streptomycin (#15070-063, Life 
Technologies, USA), 2mM L-glutamine (#25030081, Life Technologies, USA) 50ng/ml 
human recombinant M-CSF and 30ng/ml human recombinant RANKL. After the first 3 days 
of culture, medium was changed every 48h with 25ng/ml M-CSF and 100ng/ml RANKL until 
the end of the culture (5 to 6 days). Mo were also differentiated in suspension into immature 
(i.e. CD1a+, CD14-, CD16-) DCs in RPMI with 10% fetal bovine serum, 10mM HEPES, 2mM 
L-glutamine, 100ng/ml GM-CSF and 10ng/ml IL-4 for 6 days. Experimental details of Mo 
isolation and differentiation and DC differentiation can be found in (Gallois et al., 2010). DCs 
were then differentiated into either OCs using the same conditions as for Mo-OCs (Rivollier 
et al., 2004) or into different MGCs such as DC-γ17-MGC (Coury et al., 2008) with or 
without IFN-γ.  
 
Affymetrix GeneChip® assays and comparative analysis 
Primary human cultures of the following cell types were performed from several donors: Mo 
(2), DCs (4), Mo-OCs (2), DC-OCs (2), DC-derived MGCs with IL-17 (2), with IL-17 and 
IFN-γ (3). RNA extraction, anti-sense cRNA target labeling, array hybridization and scanning 
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were performed as shown previously (Gallois et al., 2010). Intra- and inter-assay 
normalizations were performed according to manufacturer’s instructions and gene expression 
values were averaged per cell type over all donors. When the mean expression value of a gene 
in a given cell type was superior to the average of all gene means in the same cell type, the 
gene was considered as expressed. As such, genes commonly expressed in both Mo-OCs and 
DC-OCs but not expressed in any other cell type used in this study were considered for 
further investigation. 
For the mathematical analysis, after intra- and inter-chip normalization, we calculated the 
mean expression level of a specific RNA in a given cell type (Xc) as follows:  
X
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where  
 Xc  is the mean expression of a RNA “X(i)” in a cell type “c” 
 i  is the number of donors for this cell type  
Then, we calculated the overall RNA expression per cell type ( c) as follows:  
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where  
c is the average expression of all probed genes “Xc(i)” in a cell type “c” 
i is the number of probe sets (i = 54 675 for all cell types) 
 
Gene Ontolgy molecular function enrichment 
Molecular functions of 115 genes resulting from the transcriptomic assay were annotated 
according to Gene Ontology and their percentages were compared against the human genome 
using the online software FatiGO (Al-Shahrour et al., 2006). Only statistically over expressed 
functions in our specific gene set were represented. Statistical relevance was determined using 
the Fischer test.  
 
Taqman Low Density Array (TLDA) 
Mo, DCs, Mo-OCs, DC-OCs and DC-17 γ -MGCs triplicate cultures were obtained from 3 
different human blood donors. RNA was extracted as mentioned in the previous paragraph, 
quantified with a Nanodrop (ThermoFischer Scientific, USA), quality-checked with an 
Agilent 2100 Bioanalyzer (Agilent Technologies, USA) and finally reverse-transcribed using 
iScript™ cDNA Synthesis Kit (#170-8891, Bio-Rad, USA) following kit protocol. 
Amplification was performed using a made–to-order Taqman Gene Expression Assay 
(Agilent Technologies, USA) according to manufacturer’s instructions. After verification with 
X 
X 
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of 18S (Hs99999901_s1) amplification (standard microfluidics technical control for 
amplification runs), relative cDNA quantities (RQs) calculated based on cycle thresholds (Ct) 
were normalized with SEC61B (Hs00606455_m1) and TBP (Hs00920494_m1) housekeeping 
genes. Then, differential expression for each gene in resorbing cells (i.e Mo-OCs and DC-
OCs) was compared with that of non resorbing cells (i.e. Mo, DC and DC-17 γ -MGCs) by 
using the latter as background in the limma parametric test (Limma package, Affymetrix, 
USA) combined with the Benjamini-Hochberg False Discovery Rate p-value adjustment. 
Adjusted p-values <0.05 were considered significant.  
 
Primary murine osteoclast cultures and transfection 
OCs were differentiated from myeloid precursors extracted from either E15 to E18 fetal liver 
(FL) or from neonatal bone marrow (BM) or spleen (Sp) of RhoE+/+, RhoE+/- and RhoEgt/gt 
mice of exactly the same age respectively described in (Schmidt JCB 2011, Destaing MBoC 
2003, (Chabadel et al., 2007). For each experiment, all cultures were started from the same 
source tissue (i.e. FL, BM or Sp) from littermates sacrificed at the same time. Once extracted 
from their respective tissues by flushing (in the case of BM) or grinding against a 100µm-pore 
nylon cell strainer (in the case of FL and Sp), these precursor cells were purified with a 
gradient of Leukocyte Separation Medium at 1250g for 20min and 20°C by aspiration of the 
gradient interface. Cells were then washed by centrifugation and put into culture with αMEM 
with 10% fetal bovine serum, 100 units/ml Penicillin, 100µg/ml Streptomycin, 2mM L-
glutamine, 20ng/ml murine recombinant M-CSF (produced by the “Production d’analyse des 
protéines” platform, UMS3444, Lyon-Gerland, France) and murine RANKL. The source of 
precursors for each experiment is mentioned in the Results section. For transfection, day-4 
OCs were detached with 0.25mM EDTA in warm PBS and transfected using the Neon® MP-
100 electroporator (Life Technologies, USA). Briefly, 0.5x106 cells were resuspended with 
2µg of pEGFP-C-RhoE (#23229, Addgene) plasmid DNA in 10µl of Buffer “R” (see kit 
protocol) then jolted with a 1720V current in 2x10ms pulses. Electroporated cells were then 
seeded on coverslips with pre-warmed medium and kept overnight. Medium was renewed the 
following day. 
 
Differentiation assays 
To quantify differentiation and fusion of FL-derived OCs (FL-OCs) from RhoE+/+, RhoE+/gt 
and RhoEgt/gt mice (Mocholi et al., 2011), the same number of precursors (2x104 cells/well) 
from E15.5 littermates was seeded in 96-well culture-treated plates and on bones slices of the 
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same size. They were then fixed at several time points (day 5, day 6 and day 8 post-seeding) 
with 4% (m/v) parafolmaldehyde in PBS for 15 min at room temperature then stained at 37°C 
using a TRAP assay kit (Sigma-Aldrich, USA) according to manufacturer's instructions. Cells 
with 3 or more nuclei that turned violet were counted as OCs.  
 
Resorption assays 
To quantify the resorbed surface per murine OC (i.e. resorption index), two methods were 
used. For resorption on bovine cortical bone slices, day-8 FL-OCs were assayed for 
differentiation then resorption was measured as mentioned in (Harre et al., 2012) (Destaing et 
al., 2003). For resorption on bone-mimicking OsteoAssay Surfaces® (OAS) (#3988, Corning, 
USA), day-4 FL-OCs were detached from plastic wells by flushing after incubation at 37°C 
for 5min in PBS + 0.25mM EDTA, counted then seeded at the same number (2x104 cells/well 
in 96-well plates) in replicate plates and cultured for 48h. To measure the total surface of the 
resorbed matrix, OCs were washed off with distilled water then the matrix was stained with a 
5% (m/v) Silver Nitrate solution. In parallel wells, the number of OCs was determined by 
TRAP staining as mentioned previously. Finally, the resorption index was obtained by diving 
the total resorbed area per well by the total number of OCs per well.   
To determine the resorption index of human DC-OCs and DC-17ϒ-MGCs on coverslips 
coated with apatite-collagen complexes (ACC) (Shibutani et al., 2000) (Saltel et al., 2004), 
day-4 DC-OCs and day-14 DC-17ϒ-MGCs (i.e. stages of differentiation where both cell types 
a terminally differentiated (Coury et al., 2008) (Rivollier et al., 2004)  were detached using 
1X Accutase® (Sigma Aldrich, USA), replated on ACC coverslips with RANKL and M-CSF 
stimulation to promote resorption. The resorbed area per cell was determined by the absence 
of matrix crystal complexes subjacent to the cell.  
Images of all substrates were captured with an AxioImager microscope (Carl Zeiss, Germany) 
topped with a CCD Coolsnap color camera (Photometrics, USA) and manually quantified 
with ImageJ software. 
 
Random migration assay 
Day-5 Sp-OCs were detached and replated at low confluence (5x104 cells/well in a 24-well 
plate) to solicit random (non-directed) OC migration. Cells were given 2h to adhere then were 
imaged in phase contrast on an inverted microscope Axiovert 100M (Zeiss) for 14 hours at 
37°C with saturated humidity. Images were acquired every 5min. Consecutive cell positions 
were determined manually using the MTrackJ plugin in ImageJ at 20min intervals so that 
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displacements were significantly greater than imprecisions due to manual tracking. Small 
front-to-back polarized OCs that< were not in contact with other cells were tracked. In other 
words, OCs that were fusing or without visible leading and trailing edges were not considered 
for this assay. Instantaneous velocity (Vi) was defined as the distance travelled between two 
consecutive points divided by the corresponding time interval (20min). Instantaneous angular 
change (Δαi) was defined as the result of the subtraction between the angles of velocity 
vectors of two consecutive displacements. Persistence of movement “Pi” was defined as the 
ratio of “di” divided by “Di”, with “di
” defined as the direct distance between the position “i” 
and the position at the start of the track and Di defined as over the length “D” of the track at a 
given position “i”. 
 
Fluorescent labeling and confocal microscopy of fixed cells 
OCs in culture on coverslips or glass-bottom plates (Mattek Corp., USA) were fixed with 4% 
parafolmaldehyde in phosphate buffered saline (PBS) for 10min at 37°C and permeabilized 
using PBS + 0.2% Triton-X-100 Triton-X-100 in PBS. All antibody dilutions and washes 
were thereafter performed with PBS + 0.1% Triton-X-100. Used primary antibodies were: 
anti-vinculin (5µg/ml final, clone hVIN-1, #V9264, Sigma-Aldrich, USA), anti-cortactin 
(10µg/ml final, #05-180, Clone 4F11, Millipore, USA), anti-paxillin (10µg/ml final, #610051, 
BD Biosciences, USA). Secondary antibodies Alexa Fluor® 488 anti-Mouse IgG (A11029, 
Life Technologies) and Alexa Fluor® 488 anti-Rabbit IgG (A-21245, Life Technologies, 
USA) were used at 2µg/ml. Then Alexa Fluor® 647 Phalloidin (A22287, Life Technologies, 
USA) was diluted 1:100. Image acquisition was performed with either a DMI4000 
microscope (Leica Microsystems, Germany) equipped with a spinning disk unit CUS22 
(Yokogawa, Tokyo, Japan) or an SP7 spectral confocal microscope (Leica Microsystems, 
Germany). For podosome colocalization studies, all images were acquired with the same 
excitation and detection parameters without reaching signal saturation. To perform pixel-to-
pixel multiplication of 16-bit images using ImageJ, non-specific signal obtained from 
negative control micrographs (cells with only secondary antibodies) was subtracted from the 
“green micrographs” on coverslips treated with primary and secondary antibodies.  
Background noise in “red micrographs” (where Alexa Fluor® 647 Phalloidin was used) was 
measured outside the cells and subtracted from each image. For each cell, the “green channel 
image” was multiplied with the red channel using the “multiplication” option of the Image 
Calculator plugin in ImageJ and the result was represented as a “32-bit float” image with a 
“Ratio” lookup table. In the resulting image, the intensity value of a given pixel is therefore 
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the results of the multiplication of the intensity values of the pixels with the same coordinates 
from the “red channel” and the “green channel”. For the measurement of SZ sizes on bone 
slices, contrast minima per field were raised so that bone autofluorescence was no more 
observed. For podosome core size measurement, background noise was measured outside of 
the cells and subtracted from entire images. The podosome core was delimited based on local 
intensity thresholds using the Find Peaks plugin in ImageJ with the following parameters: 
Gaussian blur “0.72”, Background method: “Std.Dev above mean”, Background parameter 
“0”, Statistics mode “Both”, Background level “24”, Search method “Half peak value”, 
Remove edge maxima “On”. 
 
Fluorescence recovery after photobleaching (FRAP) acquisition and analysis 
Day-4 FL-OCs were infected with 2nd generation packaging viral particles (provided by the 
“Anira-Vectorologie” platform, UMS3444, Lyon-Gerland, France) containing a pLVX-
LifeAct-mCherry lentiviral construct (obtained by inserting LifeAct coding sequence between 
EcoR1 and BamH1 site in pLVX-mCherry-N1 vector, #632562, Clonetech, USA) at a 
multiplicity of infection of 10:1 in 1ml per well of a 6-well plate. OCs were incubated 
overnight and medium was changed in the morning. OCs with clusters and rings were 
fluorescent on day 6 (48h post infection) and imaged using a DMI4000 microscope (Leica 
Microsystems, Germany) equipped with a spinning disk unit and a FRAP module piloted by 
iLas2 software (Roper Scientific, USA). mCherry was excited with a 561nm laser and 
bleached with a 473nm laser at 100% in 3 iterations. Acquisition was optimized to obtain 
maximal signal without any saturated pixels and defined in 3 temporal phases: Prebleach 
phase (5 acquisitions, 5sec time interval between consecutive acquisitions), first postbleach 
phase (20 acquisitions, 3sec interval) and second postbleach phase (11 acquisitions, 30sec 
interval). The mean relative fluorescence intensity (RFI) of a given region of interest was 
measured and normalized as mentioned in (Negi and Olson, 2006). The obtained RFIs were 
curve fitted and plotted using the formula in (Negi and Olson, 2006) with consideration of the 
guidelines in (Hardy, 2012). Statistical analysis of recovery half-times was calculated from 
data fitting using the “Do the best fit values of selected parameters differ between datasets 
differ” function in Prism 6 (Graphpad software, USA) (Weisswange et al., 2009). 
 
Immunoblotting  
Day-5 BM-derived OCs (BM-OCs) were lysed in 2X Lameli sampling buffer, ran on SDS-
PAGE and blotted on PVDF membranes. Primary antibodies were: anti-cofilin (1:1000, clone 
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D3F9, #5157, Cell Signaling Inc, USA), anti-phospho(Ser3)-Cofilin (1:1000, clone77G2, 
#3313,Cell Signaling Inc., USA), anti-β-tubulin (0.3 mg/ml final, T4026, Sigma-Aldrich, 
USA), anti-Rock-I (1:1000, clone C8F7, #4036, Cell Signaling), anti Mypt1 (10µg/ml, A300-
888A, Bethyl Laboratories Inc., USA), anti-p(696)-Mypt1 (1:1000, STA415, Cell Biolabs 
Inc, USA). Enhanced chemiluminescence detection was performed using Amersham ECL 
Prime Western Blotting Detection Reagent (RPN2232, GE Healthcare, USA). 
 
Statistics 
Comparison of means was performed with the two-tailed Mann-Whitney non-parametric test 
in Prism 6 (Graphpad). Unless noted otherwise, values mentioned in the text are Mean ± 
SEM. confidence level for all tests was 95%. A p-value < 0.05 was considered as significant 
(*), p < 0.01 as highly significant (**), p<0.001 as very highly significant (***). Error bar 
annotation for each sample is defined in figure legends.  
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FIGURE LEGENDS 
 
Figure 1. DC-17 γ -MGC, like OCs, are able to make podosomes but not functional SZs 
for resorption. (A) Cells seeded on a resorbable apatite-collagen coated matrix. As expected, 
DC-OCs form SZs (actin is in white in the left panel, in red in the middle panel) and are able 
to resorb bone (resorbed area in outlined with a white dotted line, right panel). DC-17 γ -
MGCs make dysfunctional SZ structures and are unable to resorb the matrix. Yellow line 
outlines the cell periphery. Scale bar is 20µm. (B) Quantification of actin-containing 
structures and resorption areas per cell. Left: Percentage of fixed DC-OCs exhibiting SZs 
compared with DC-17 γ -MGCs exhibiting dysfunctional SZ structures. Middle: box-and-
whiskers plot showing surface area of SZ and dysfunctional SZs. Represented on the plot are 
minimum and maximum values (whiskers), mean (+), median (middle line in grey box), and 
25% and 75% quartiles (limits of grey box). Right: histogram of the resorption index (area of 
resorbed matrix per cell) of the two cell-types. Error bars are SEM.  
 Figure 2. Cytoskeleton organization in DC-17 γ -MGC compared to Mo and DC-Ocs.  
Cells seeded on glass showing colocalization of paxillin or vinculin (green) with actin (red) at 
the podosome cloud (upper panel and middle panel, respectively) and cortactin (green) with 
actin (red) at the podosome core. Multiplication images where calculated pixel-to-pixel from 
actin combined with one podosomal protein at a time and are represented in 32-bit float 
images with “Ratio” lookup table. The calibration bar indicates the correspondence of false 
color to 32-bit pixel fluorescence intensities. Scale bar is 10µm in first 4 columns and 2µm in 
magnified square insets.  
 
Figure 3.  Workflow and results of the comparative transcriptomic study used to probe 
for OC-specific genes. (A) In vitro treatments used for differentiation and fusion of human 
Mo into resorbing OCs, of immature DCs into resorbing OCs and of DCs into non resorbing 
MGCs by addition of IL-17 and/or IFN-γ. Genechip® Microarray technique was applied to 
total RNAs obtained from each of cell type followed by mathematical comparison to sort out 
115 mRNAs highly and exclusively expressed in Mo-OCs and DC-OCs. Validation of the 
upregulation of the 115 genes in OCs by Taqman Low Density Array performed on cDNAs 
from Mo, DCs, Mo-OCs, DC-OCs, and DC-17ϒ-MGCs. Due to the high cut-off value for 
detection, only 56 genes out of 115 were found to be expressed in OCs. Among the these, 6 
genes (grey columns, names in red) were undetected neither in Mo, DCs nor in MGCs. (B) 
Enriched Gene Ontology Molecular functions in the 115 OC-speficic genes compared to the 
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human genome identified by the online tool FatiGO. Second: secondary, TA: transporter 
activity, TTA: transmembrane transporter activity, NT: neurotransmitter. 
 
Figure 4. RhoE is dispensable for primary murine OC differentiation and fusion but is 
required for bone resorption. (A) Micrographs showing TRAP staining of FL-OCs 
differentiated with M-CSF and RANKL on tissue culture-treated plates after 5, 6 and 8 days 
of culture. Scale bars are 200µm. Histogram shows a time-scale quantification of the number 
of OCs (TRAP-positive cells with 3 or more nuclei) per well on tissue culture plastic and 
bone slices. (B) Plot of the number of nuclei per OC as indicator of OC fusion on tissue 
culture-treated plastic. (C) Upper panel: micrographs and plot showing resorption index of 
OCs seeded for 8 days on bone. Resorbed bone is stained with toluidine blue (violet surface 
outline with white dotted lines). Scale bar is 200µm. Graphs shown mean ± SEM. Lower 
panel: micrographs and plot showing resorption index of OCs seeded for 48 hours on a bone-
mimicking substrate (OsteoAssay plates). Unresorbed matrix is stained with silver nitrate 
(grey). Resorbed surface is not stained (white). Scale bar is 500µm. 
 
Figure 5. RhoEgt/gt OCs exhibit smaller SZs. Micrographs of actin-stained OC seeded on 
cortical bone slices showing smaller SZs sizes. Yellow lines show cell periphery inferred 
from overcontrasted images. SZs were determined by their circular shape and strong 
fluorescence. SZ outlines were manually drawn and inner surface areas where quantified and 
calculated mean ± SEM was plotted in the graph.  Scale bar is 50µm. 
  
Figure 6. Podosome size, number and superstructure patterning are regulated by RhoE 
in OCs. (A) Upper lane: micrographs of FL-OC podosomes stained with actin showing a 
reduced number of podosomes in RhoEgt/gt OCs Yellow line in the zoomed images (lower 
lane) shows cell periphery (Upper lane). Lower lane: zoom of white insets in upper lane using 
“Ratio” lookup table colors. White circles depict peripheries of podosome cores as identified 
by local intensity thresholds using ImageJ (see Materials and Methods) followed by manual 
curating. The calibration bar indicates the correspondence of false color to 16-bit pixel 
fluorescence intensities (B) Left: Whisker-box plot depicts minimum and maximum number 
of podosomes per cell (whiskers), 25% and 75% quartiles (lower and upper limits of boxes) 
and median (midline of boxes). Middle: Histogram showing mean podosome core size with 
SEM bars. Left: Frequency distribution histogram of podosome core sizes showing a shift 
toward bigger sizes in RhoEgt/gt OCs. Horizontal axis shows the centers of intervals. (C) 
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Micrographs of actin-stained OC cultures. # indicates OCs with SZ-likes. Yellow lines 
delineate the periphery of cells with podosome rings.  Histogram shows counts of clusters, 
rings and SZ-likes per well. Note the decrease in RhoEgt/gt OCs in stable and metastable 
podosome superstructures i.e. clusters and SZ-likes, respectively, as well as the increase of 
transient superstructures, i.e. rings.  Scale bar is 100µm. 
 
Figure 7. FRAP of LifeAct-mCherry reveals slower turnover in podosome clusters and 
rings in RhoEgt/gt FL-OCs. (A) Micrographs of timeframes pre- and post-photobleaching of 
LifeAct-mCherry-expressing FL-OCs on day 5. Yellow insets show bleached areas. Scale bar 
is 10µm. (B) Mean fluorescence recovery of photobleached areas normalized to mean 
fluorescence of the same area before photobleaching and to the non-bleached remainder of the 
cell during recovery. Data was gathered from n>12 samples per genotype and per structure 
from 2 independent cultures. Each culture was differentiated using a pool of precursors from 
at least 3 animals of the same genotype. Dots are means of mean relative fluorescence. Lines 
are fitted curves. Bars are SD. (C) Actin recovery half-times calculated from recovery curves. 
Recovery half-times are increased in clusters from 9.8 sec ± 1.4 in RhoE+/+ to 19.7sec ± 3.5 in 
RhoEgt/gt OCs and in rings from 24 sec ± 3 in RhoE+/+ to 34.4 sec ± 3.8 in RhoEgt/gt.  
 
Figure 8. RhoEgt/gt OCs show impaired migration. (A) Upper panel: micrographs of 
timelapse imaging showing day-5 Sp-OC migration tracks (red). Scale bar is 40µm. Lower 
panel: Representative rose plots of 5 RhoE+/+ and 5 RhoEgt/gt OC migration tracks for a total 
duration of 8h per track. (B) Plots of migration parameters of migrating OCs (RhoE+/+: n-=84 
tracks, 1870 time points; RhoEgt/gt: n=39 tracks, 1214 time points). Left: instantaneous 
velocity of displacement (i.e. speed between 2 consecutive positions). Middle: instantaneous 
persistence of OC migration (Pi=Di/di).  Right: Frequency distribution of angle change 
between 2 consecutive movements. Raw values are represented with dots and fitted with a 
Gaussian function. Error bars are SEM 
 
Figure 9. RhoE is cytoplasmic and inhibits Rock-I from phosphorylating Cofilin. (A) 
Micrograph of a day-5 BM-OC expressing RhoE-GFP (green) 24h post-transfection and 
stained for actin (red) showing ubiquitous cytoplasmic localization of RhoE. (B) 
Immunoblotting of total Cofilin, phosphorylated Cofilin at Serine 3 (p(Ser3)-Cofilin), Rock-I 
and β-tubulin of serum-induced day-5 BM-OCs treated or not with 10µM Y-27632 (a Rock 
inhibitor) after 2h of serum starvation. Quantification of protein expression of p(Ser3)-Cofilin 
  108
normalized to total Cofilin reveals a 2.3 fold increase in RhoEgt/gt OCs compared to RhoE+/+ 
OCs without affecting overall Rock-I levels.  
 
 
SUPPLEMENTARY DATA LEGENDS 
 
Figure S1. Expression ratios of the 115 genes highly expressed in OCs and not expressed 
in Mo, DCs and DC-MGCs as quantified by GeneChip® microarray.  The value of each 
gene corresponds to the log10 of the ratio resulting from dividing the average expression in 
OCs by the average expression in Mo, DCs and  DC-MGCs described in Fig. 2A.  
 
Figure S2. Expression values (arbitrary units) of the 115 genes highly expressed in OCs 
(Mo-OCs in green; DC-OCs in violet) and not expressed (i.e. below average gene expression 
within each cell type) in Mo (blue), DCs (red) as quantified by GeneChip® microarray. 
Stacked bars depict the mean values of expression of a given gene per cell type. 
 
Figure S3. Mypt1 phosphorylation is not Rock-dependent in OCs  
OCs were serum-starved for 2h then treated or not with Y-27632 (30µM). Rock-I inhibition 
resulted in decreased phosphorylation of Cofilin on Serine 3 (normalized over total Cofilin) 
and did not affect Mypt1 phosphorylation on Threonine 696 (normalized over total Mypt1). 
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CHAPTER 3: DISCUSSION AND 
PERSPECTIVES 
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The cell biology of the OC is an exciting field of research. It allows the understanding of 
fundamental processes such as cell migration, fusion, matrix degradation, and cytoskeletal 
remodeling in a physiologically relevant context, that of bone remodeling and homeostasis. 
OCs differentiate and fuse from mononuclear monocytic precursors to become large 
multinucleated giant cells. After reaching maturity, these “big” cells roam on the bone surface 
and degrade it. Meticulous regulation of OC differentiation and mature function is necessary 
for a healthy bone tissue and, therefore, a healthy organism. Conversely, deregulations of OC 
processes can lead to bone pathologies. The general purpose of my thesis was to indentify 
new molecular mechanisms that regulate OC-mediated bone resorption with particular interest 
to OC differentiation and OC cytoskeletal organization.  
 
 
OSTEOCLAST DIFFERENTIATION IN PATHOLOGY: THE LINK BETWEEN AUTOIMMUNITY AND 
BONE LOSS  
 
 
Osteoclastogenesis is the first rate-determining step in bone resorption. While studying the 
mechanisms promoting massive bone loss in Rheumatoid Arthritis (RA) in vivo and in vitro, 
we found that increased differentiation but not resorption capacity of OCs was the reason 
behind this bone loss. RA-induced osteoclastogenesis mainly consisted of three phases. First, 
autoantibodies that rise years before the onset of RA recognize a genetically mutated and 
post-translationally modified protein, mutated citrullinated vimentin (MCV), in OCs. This 
recognition stimulates OC secretion of an immune cytokine TNF-α, which known for its acute 
osteoclastogenic potential. Finally, by an amplified autocrine loop, TNF-α not only induces 
OC precursor proliferation and differentiation, but also promotes its own expression in these 
cells (Harre et al., 2012). Therefore, this study constituted the first link between the three 
main elements in RA: the major autoantibody (anti-MCV), the prevalent clinical aspect (bone 
loss) and the dominant cytokine (TNF-α) (Figure 17). 
Although it is now clear that MCV can be exported to the surface of OC, future efforts should 
be made to elucidate the molecular mechanisms induced by these autoantibodies after they 
bind MCV at the surface of the cell.  
  124
 
Figure 17. The current model of autoantibody-induced osteoclastogenesis in RA. 
Autoantibodies against citrullinated proteins (ACPAs), with high specificity against 
citrullinated vimentin are produced by plasma cells. These ACPAs bind to osteoclast 
precursor cells and induce the release of TNF, which in turn enhances the differentiation of 
these cells into mature osteoclasts (Schett and Gravallese, 2012). 
 
 
 
ORGANIZATION OF THE OSTEOCLAST CYTOSKELETON DURING BONE RESORPTION 
 
Differentiated OCs dispose of a unique cytoskeletal machinery that allows them to degrade 
bone. Although podosome formation is not exclusive to OCs, these cells are the only ones that 
arrange their podosomes to form sealing zones (SZs). As its name suggests, the role of the SZ 
is to ensure proper confinement (“sealing”) of degradation molecules secreted via the ruffled 
border into the subjacent resorption lacuna.  In fact, the formation of the SZ is concomitant 
with OC apico-basal polarization and subcellular compartmentalization. Not only does the OC 
form a ruffled border that is characterized by vesicular secretion and proton pump activity and 
surrounded by a SZ, the cell also commits to other resorption-related functions such as 
microtubule stabilization and transcytosis through the apical pole. Furthermore, the OC also 
transitions into an active podosome-driven migration phase between two resorption phases, 
thus adding a second type of polarization, i.e. antero-lateral, to the dynamic process of bone 
resorption. Given its involvement in all the processes of resorption, the OC cytoskeleton was 
the main subject of research in this thesis. Discussed below are the significant findings from 
the two main studies, Hu et al and Georgess et al: how they elucidate some aspects of OC 
function but also why they make grounds for new perspectives.  
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Novel actin-organizing genes indentified in osteoclasts 
With the perspective of finding new pathways involved in OC function, we have performed a 
differential transcriptomic screen comparing, on one hand, bone resorbing human OCs and, 
on the other hand, non-resorbing multinucleated cells from the same OC precursors.  We were 
then able to establish a list of 115 genes that were highly and exclusively expressed in OCs.  
Gene Ontology annotation of these genes has revealed that this list contained an enrichment 
of certain cellular functions in OCs compared to the percentage of the functions in the Human 
genome. One of the enriched functions was “Cytoskeleton binding” including is sub-category 
“Actin binding”, thus highlighting the importance of the cytoskeleton in general and actin 
filaments in particular to OCs. Additionally, other enriched functions never before addressed 
in OC have been identified, e.g. “Active transporter activity”. 
In a second step of this comparative study, we verified with higher quantitative precision the 
expression levels of the 115 genes in the same set of cells used for the transcriptome analysis.  
This allowed the validation of 6 candidate genes  (out of the original 115) as OC-exclusive 
genes in our model: Tm4sf1, Pls3, Myo1b, AK5, LNX1 and RhoE. Previous studies have 
provided data linking these genes either with OCs and/or with the actin cytoskeleton in other 
cells. This highlights once more the necessity of tight cytoskeletal regulation in OCs. PLS3, a 
member of the fimbrin family known for organizing actin filaments, has been shown to 
colocalize with OC podosomes but how it might actually regulate podosomes is unknown. 
AK5 expression is RANKL-dependent in osteosarcoma cells but its function in OCs has not 
been addressed. TM4SF1, a member of the tetraspanin family described for their interaction 
with integrins at the cell surface, organizes adhesion structures and cell migration. It would be 
interesting to find if it is implicated in integrin signaling during OC migration. LNX1 is 
responsible for the ubiquitinilation of Src, a major podosome regulator. Myo1B, a member of 
the myosin superfamily, is localized in filopodia, protrusive adhesion-type structures, and 
regulates Arp2/3, a known podosome component, in Golgi-related actin foci. Finally, RhoE, a 
constitutively active GTP-binding protein of the Rho family, inhibits stress fibers and focal 
adhesions by inhibiting the Rho-Rock pathway. In summary, our comparative model has 
provided new putative regulators of OC pathways.  
Because of their high expression in OC and the cytoskeletal functions that these gene play in 
other cell types, their study should bring new information on the regulation of OC 
cytoskeleton.  
Considering the importance of RhoGTPase signaling pathways in OCs, we focused our 
interest on RhoE. We confirmed the importance of RhoE for podosome organization during 
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bone resorption by its ability to inhibit Rock-activity in vitro. Details of the cellular and 
molecular mechanisms controlled by RhoE and how they have provided new insight into the 
OC mode of function are given in the subsequent sections of this chapter. In the future, 
investigation of the role of RhoE will evolve around its function as a physiological regulator 
of bone remodeling. Two distinct in vivo models should be used to investigate the 
physiological role of RhoE. First, RhoE OC-specific deletion in mice could be achieved by 
crossing RhoE-floxed mice with mice expressing Cre recombinase under the Cathepsin-K 
promoter, which is specific to OCs. Both mouse lines are available. The finding of an 
osteopetrotic bone phenotype in OC-specific RhoE-deleted mice would then be the ultimate 
proof of the dependency of bone resorption on this gene. The second model, which already 
exists and should be used for the in vivo investigation, is the RhoE ubiquitous knockout by 
genetrap (RhoEgt/gt). These mice present severe developmental defects which lead to their 
premature postnatal death. Among the existing abnormalities, RhoEgt/gt mice are strikingly 
smaller at birth and display growth retardation compared to wildtype littermates. The 
underlying causes of this smaller size could be arrested chondrogenesis, arrested osteogenesis, 
and/or the absence of bone resorption, which is the first step of the cartilage-to-bone 
transition. Thus, to uncover the global role of RhoE in bone, its tissue-specific functions 
should be assessed. Histological analysis of bone sections should provide indications of 
RhoE-depleted OB differentiation and bone formation. Furthermore, micro-computed 
tomography (µCT) studies of bone tissues in each of the proposed murine models would 
finalize the analyses by allowing accurate quantification of bone histomorphometric 
parameters.  
 
The role of podosomes in adhesion and spreading 
Before the OC migrates and resorbs bone, it needs to adhere the extracellular matrix. The 
relationship between cell adhesion and podosome organization has been long admitted by 
scientists, but its details were poorly understood. We have shown that, as soon as the OC 
contacts it substrate but before it is properly spread, intracellular waves of unorganized actin 
are pooled in membrane protrusions at the edge of the cells. After 10-20 minutes, podosome 
assembly begins and the cell membrane is laterally stretched to make even bigger protrusions 
than ensure the complete spreading of the cell. Now given the fact that actin recruitment in 
podosomes occurs at the level of the adhesion plaque at the immediate vicinity of the cell 
membrane (see Chapter I - sections III.2 and III.3), it would mean that podosome assembly 
(and namely podosome core growth) in a bottom-up manner exerts a force on the membrane 
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itself, pushing it away from the center of the cell and thus induces spreading. Our findings 
converge with other data describing matrix-dependent podosome dynamics (Labernadie et al., 
2010; van den Dries et al., 2013b). 
Conversely, the inhibition of integrins in an already-spread OC results in two sequential 
phases of detachment: (1) within the first seconds, podosomes disassemble but the cell 
remains spread, then (2) the cell retracts and detaches from the substrate. These observations 
allow the conclusion that podosomes are not the only mediators of adhesion in OCs, at least in 
a short period of time, but that they greatly enhance and maintain it.  
  
Osteoclast saltatory migration 
An adherent and spread OC forms podosomes that grow in a confined space during their 
assembly phase. The growth of podosomes in close vicinity within a cluster leads to them 
"pushing" each other, thus resulting in a ring pattern. While rings expand by rapid podosome 
assembly and disassembly in an outward radial direction, they apply traction forces on the 
matrix thus steering a part of the cell that becomes a leading edge. Our observations have 
shown that, within one OC, at least two podosome rings grow simultaneously, hence creating 
two leading edges at opposite directions. At this point, the migratory OC adopts a triangular 
form with two tips occupied by podosome rings and the third tip constituting the trailing edge 
of the cell. Due to the transient nature of rings, one of the two migratory rings eventually 
collapses before the other. The most stable ring then determines the migratory direction of the 
entire cell, after a characteristic delay period, in following that of its proper growth. These 
events translate into a cyclic biphasic migration scheme: (1) Straightforward movement: 
while the two rings grow at the front of the cell (in positions similar to two tips of a triangle) 
and the trailing edge of the OC passively follows behind (positioned at the third tip of the 
triangle), the OC moves forward in a straight direction, then (2) Angular switch: the rings 
reach a maximal distance between them, they stretch and flatten the triangle, one rings 
collapses and the other determines the sudden “jump” of the entire cell in its direction. This 
jump has a characteristic deviation of 90° from the previous straightforward phase direction 
and marks the start of a new straightforward phase which will eventually perpendicularly 
deviate from itself. The cycling of angular switching in the OC trajectory allows for a large 
mean squared displacement, which is probably needed by the OC to cover a maximal surface 
area in the search for spots to degrade. 
Although the saltatory migration of OC is intrinsically heterogeneous, its characteristic 
parameters can be experimentally quantified. In the normal situation, the OC migrates at an 
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average instantaneous velocity of 0.8µm/sec and with a track persistence value of 0.45 (“0” 
being a constant rotation of the cell around itself and “1” being a perfectly straight line). From 
now on, these parameters can be used by OC biologists for quantitative assessment of OC 
migration in different experimental conditions. We have used them to assay for the role of 
RhoE in OC migration. For example, while investigating the function of RhoE in OCs, we 
saw that RhoE-/- OCs migrated with reduced instantaneous velocity compared to wildtype 
OCs, but also that their persistence was reduced due to increased angular turns and decreased 
straightforward motion. Therefore RhoE deletion in OCs changed their migration from 
saltatory to simply “turning in circles” around themselves.  
 
Regulation of podosome internal dynamics and collective patterning 
Podosome dynamics need to be tightly regulated by the OC in order to properly organize into 
a SZ. The presence of classical structural markers such as actin, vinculin, paxillin and 
cortactin within podosomes of OCs or of other multinucleated giant cells from the same 
lineage can lead to circular patterning of podosomes but is insufficient to form a functional 
SZ capable of ensuring bone resorption. This finding supports the existence of OC-specific 
molecular mechanisms to podosomes that distally support SZ formation by upstream 
regulation of podosomal proteins. Indeed, although their upstream distal regulators are not 
always known, some podosomal proteins like cortactin and cofilin have been previously 
shown to undergo posttranslational modification, such as tyrosine phosphorylation, which 
have consequences on actin dynamics in podosome. The idea of “distal upstream regulation” 
is further confirmed by data derived from a single bone marrow-derived OC population. In 
absence of the expression of RhoE, which is not a structural component of the podosome, 
podosomes can still assemble but SZ formation is abnormal. In fact, RhoE regulates 
podosomes by modulating cofilin-mediated actin turnover.  
 
The resorption-migration cycle 
In order for OCs to efficiently degrade bone and ensure its renewal, this cell needs to fulfill 
two functions: resorption and migration to find new resorption target sites. This would mean 
that the podosomes in OCs needed to maintain dynamic patterning transition between SZs 
rings. The data obtained on the role of RhoE in OCs has demonstrated how one molecular 
pathway links internal podosome dynamics to both ring-driven migration and SZ-mediated 
resorption. This provides proof, additionally to that already found in the literature, of the 
necessity of podosomes to these cellular processes. However, the gathered data did not bring 
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new insight as to the spatio-temporal regulation of the hypothetical resorption-migration 
cycle. To address this aspect, one would need to distinguish podosome migratory rings from 
SZs, which is not possible in a static, fixed setting because they are both circular podosomal 
patterns that contain the same proteins. However, the discrimination between rings and SZ 
could be addressed by timelapse microscopy of OCs with fluorescently labeled actin and 
seeded on bone (Figure 18). The quantification of morphological and kinetic parameters such 
as pattern lifespan and size, circular expansion rate, pattern displacement, cell displacement, 
etc…, followed by principal component analysis should allow the identification of two 
subsets (rings and SZ) within these circular podosome patterns. This approach might provide, 
once and for all, a clear demonstration of how the OC coordinates displacement with 
resorption.  
 
 
Figure 18. Merged micrographs of the actin cytoskeleton in a primary osteoclast in three 
time points. A murine bone marrow-derived OC expressing fluorescent LifeAct (an F-actin 
probe) displays evolving circular podosome patterns (either ring or SZ) during resorption of 
bovine bone. Between the 1st position at 0 min (red) to the 2nd position at 19 min (green), de 
novo podosome assembly sites have moved suggesting a ring-driven migration phase. 
Between the 2nd to the 3rd position (magenta), at 19 min and 39 min 40 sec, respectively, 
podosome assembly site have been partially conserved and the circular pattern has expanded. 
This suggests ring stabilization and transition to SZ.  
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Signaling in osteoclasts 
Given the dynamic nature of the “OC cytoskeleton in action”, its study using biophysical 
approaches is both intriguing and insightful. However, the increasingly acquired data 
demands biochemical explanations: What are the signals transmitted to the OC cytoskeleton? 
What are the genes and proteins that transmit them? How does the OC synchronize its 
cytoskeleton with its entire polarization? 
Although these questions are very broad, partial answers might be provided by identifying 
new molecular pathways in OCs. The list of candidate genes that we have provided could 
serve as starting points for the identification of such pathways.  
Another source of insight into OC signaling might be the characterization of the interplay 
between members of the Rho GTPase family in OCs. These small proteins are involved in a 
variety of cellular mechanisms and act as differential molecular switches in different parts of 
the cell in response to different intra- and extracellular stimuli. 
We have provided a new molecular mechanism depicting the role of RhoE in the regulation of 
podosome dynamics and, subsequently, bone resorption.  RhoE acts as an inhibitor of Rho 
kinase (Rock) and thus prevents Rock-mediated cofilin phosphorylation. Finally, non-
phosphorylated cofilin ensures fast actin turnover in podosomes. Although cofilin has been 
confirmed as a Rock target and therefore an indirect target of RhoE, Rock has other 
downstream targets in OCs and differentially modulated by binding to Rho or to RhoE. In 
fact, while RhoE inhibits Rock, Rho promotes its. Besides Rock, Rho (A/B/C) can also act via 
other effectors in the OC such as mDia to regulate microtubules and podosome patterning. 
Another GTPase that has been shown important in OCs is Rac. Rac has been shown to be 
essential for OCs and to be activated by Dock5 in OCs.  
These three GTPases, Rho, RhoE and Rac, are present in OCs. The functions of Rho and Rac 
is conveyed by their ability to catalyze GTP to GDP and can be therefore be induced or 
repressed in different parts of the cell. These 2 GTPases are also known for their antagonistic 
functions vis-à-vis one another. RhoE, on the other hand, is an atypical Rho family member, 
that is constitutively active. Its lack of GTPase activity allows is be continuously linked to 
GTP and therefore remains active, although post-translational modifications have been shown 
to modulate its activity. RhoE and Rho are also known to have antagonistic functions 
pertaining to the actin cytoskeleton, mainly through modulating Rock activity.  
A more detailed molecular scheme is needed for a full understanding of the GTPases in OCs: 
how they are spatially and temporally expressed, activated and localized along the OC 
lifespan.  
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